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SCHALK WILLEM PIENAAR. 
It is as easy to dream a book 
as it is hard to write one. 
Balzac. 1836. 
A critic knows more than the author he criticizes, 
or just as much, 
or at least somewhat less. 
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ABSTRACT. 
Liver transplantation is an accepted form of treatment 
in advanced liver disease. The procedure qualifies as one 
of the most severe surgical insults that can be inflicted 
upon a patient. Despite an ever increasing number of 
clinical and experimental transplants, a vast number of 
unanswered questions remains about the effects of storage 
and transplantation per se, on the functions of this 
complex organ. The administration of drugs and blood, with 
the effects of the donor state and preservation damage 
obscure changes in parameters that are inherently due only 
to the process of transplantation, 
Changes in calcium and other electrolyte homeostasis, 
liver function assessment, acid base metabolism and 
coagulation defects that are seen after liver grafting, are 
of particular interest to transplant physicians. Current 
clinically employed indices of liver function, such as 
enzyme levels, are notoriously lacking in specificity and 
sensitivity, 
The aim of the study was to investigate in the 
experimental situation, the effects of standardised 
preservation and transplantation, without the added effects 
of blood transfusion or immunosuppressive drug 
administration, upon calcium and other electrolyte 
homeostasis, liver function and coagulation changes. 
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Furthermore, reliable indicators of liver function and/or 
damage were looked for. It was not an investigation into 
preservation methods to determine superiority of one or 
another of these methods, but an evaluation of changes 
occurring utilising established and clinically proven 
methods of preservation. 
Since researchers in the J.S. Marais laboratory, as 
well as their international counterparts, have experienced 
problems in successful storage of the pig liver for periods 
longer than 9 hours, a storage duration of six hours was 
chosen for maximum reproducibility. 
A brief overview of liver transplantation history has 
been given, available literature perused and used in 
assessment and discussion of data obtained. 
Five groups of six animals were used for orthotopic 
liver transplantation. Two groups were autografted with a 
non-flushed and Ringers lactate flushed liver respectively. 
Two groups were allografted with livers stored in Collins 
and University of Wisconsin solutions respectively. A fifth 
group was transplanted with a liver stored for six hours by 
surface cooling alone, without any flushing at all. The 
latter method has not been described in experimental or 
clinical liver transplantation before. No immunosuppression 
was used in any animal, to eliminate 
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the effects of hepatotoxic drugs. No blood was transfused 
at any point during or after the transplant. An animal 
survival rate in excess of 90%, for seven days or longer, 
was aimed for and obtained. 
Blood sampling was done at short intervals in the 
immediate postoperative period up to six hours and daily 
for a week. All currently used clinical parameters were 
determined, as well as indicators which are known, but 
novel in transplantation. 
Changes in total and ionised calcium values occurred 
in all groups and no explanatory mechanism could be 
identified. There was no correlation in changes between 
total and ionised calcium, nor any correlation with calcium 
content of preservation fluids. A reciprocal change in 
magnesium was identified. 
Acid base metabolism was markedly changed during and 
after the transplant. An increase in serum bicarbonate 
indicated survival, and a persisting metabolic alkalosis 
was seen in all survivors. Sodium and potassium values did 
not show marked changes, except for a temporary 
hyperkalaemia immediately following reperfusion. Serum 
values of liver transaminases were not found to be of value 
to discriminate between groups. Protein metabolism was not 
affected by transplantation. Glucose metabolism was 
markedly affected by transplantation and even more so 
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by poor function. Early return of normal glucose metabolism 
indicated survival. Lactic acid metabolism was 
conspicuously altered during transplantation and could also 
be regarded as an indicator of hepatocyte function. 
Coagulation in this series of experiments was affected 
negligibly and not thought to be influenced by 
transplantation of a normal liver under ideal 
circumstances. 
Thus, changes in values wi~hin groups and variance 
between groups, if any, were described and possible 
mechanisms causing variation discussed. New indicators of 
good liver function post-transplant were identified. 
The conclusion was reached that the process of 
transplantation per se does cause major changes in 
electrolyte and acid-base metabolism, but that coagulation 
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A mingled monster of no mortal kind: 
Behind, a dragon's fiery tail was spread, 
A goat's rough body bore a lion's head, 
Her pitchy nostrils flaky flames expire, 
Her gaping throat emits eternal fire. 
ILIAD, VI, 180. 
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PROLOGUE 
Replacement of non-functioning or malfunctioning 
organs has captured the imagination of surgeons for over two 
thousand years. The thrust was certainly not the desire to 
create a monster "breathing eternal fire'' but to prolong 
life and ease suffering. 
Legend has it that St. Cosmos and Damian used a 
cadaver limb to replace same affected by malignancy. Liver 
transplantation has a much more recent history and although 
performed clinically since early 1960's, only became a 
realistic treatment option for end stage liver disease with 
the advent of cyclosporine in 1976. 
Liver transplantation is unique in the sense that 
the grafted organ has to function immediately, unlike the 
transplanted kidney or heart, where backup systems such as 
dialysis and cardiac bypass machines exist to manage primary 
non-function of grafted organs. There is no machine that can 
take over the complex functions of the liver. 
Changes in biochemical and haemostatic parameters 
have been associated with liver transplantation since it's 
inception. These observed phenomena were, and are, due to a 
multitude of factors existent in both donor and recipient. 
A complex interplay of effects of donor status, 
preservation and hypothermic organ damage, recipient 
disease, blood transfusion, administered drugs and 
immunological phenomena makes it difficult to 
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associate the various changes occurring during and after 
clinical liver transplantation with precipitating causes of 
such changes. It is of the utmost importance to detect a 
non-functioning transplanted liver as early as possible, yet 
markers of liver damage and function are notoriously lacking 
in sensitivity and specificity. Tests to determine early 
abnormalities are necessary to indicate functional status, 
and should be as uncomplicated and non-interventional as 
possible for the widest possible application. 
In the experimental laboratory, under controlled 
conditions, it is possible to elicit those changes in 
biochemical and haemostatic values that are inherently due 
to the process of transplantation alone and these changes 
may then be compared to those obtained with current 
preservation techniques. Such a study could be conducted 
without the outside influences of drugs and blood 
administration. Simultaneously, those modalities that are 
currently used as indicators of liver function after 
transplantation, could be put to test and possible new 
indices identified. 
A study was set up in which currently accepted 
storage techniques were used to preserve pig livers for six 
hours. Furthermore, a novel concept of surface cooling 
(simple cold storage) alone for six hours was employed in 
one group of animals, All modalities described are in 
current practical experimental or clinical use except the 
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"simple cold storage" method which has not been used in 
clinical liver transplantation before. The autograft 
transplant model, without any flushing of the liver, was 
used as reference. All donor animals were normal; the effect 
of the donor state was excluded. 
Minimal dosage heparin, for spleno-jugular 
veno-venous bypass, as used in this study, has become 
standard practice in the J.S. Marais laboratory. Indicators 
of hepatic function identified in the course of this study 
are currently being investigated in clinical 
transplantation, as well as during inflow occlusion, in 
elective liver resection. 
In 33 consecutive porcine liver transplants three 
animals did not survive for seven days. Each of these came 
from a different group and it was postulated that 
non-survival was unrelated to technique or methods used in 
that particular group. 
An understanding of the effects of storage and 
transplantation per se might be helpful in assessing 
biochemical and haemostatic changes in the clinical 
situation, as well as being indicative of function or lack 
thereof. 
The aim of this study was to obtain 100% survival 
of transplanted animals so that preservation damage did not 
complicate the observations to be made. The study was not 






A brief overview of some of the most important aspects of 
both experimental and clinical liver transplantation is 
given. The scope of this study makes it impossible to 
include all the important milestones reached over the last 
thirty five years, but an attempt has been made to 
highlight aspects most relevant to this dissertation. 
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The first report of experimental liver transplantation 
is usually ascribed to Welch ( 1955), 3 6 There is no doubt 
that Welch's report paved the way for subsequent 
experimental work leading up to current day clinical liver 
transplantation. Welch's report was an account of a liver 
transplanted heterotopically into the right iliac fossa of 
a dog, The vascular supply of the extra liver was as 
follows, 
1, Donor portal vein to inferior vena cava. 
2, Donor hepatic artery to common iliac artery, 
3. Donor inferior vena cava to inferior vena cava, 
4. Donor cholecyst to duodenum. 
Welch and his co-workers subsequently (1956) performed 
more experimental transplants in dogs, 34 using the 
orthotopic position. There was then a lapse in reports of 
experimental liver transplantation until the dedicated 
pursuit of this branch of surgery was started by Moore in 
1959, 39,40 followed by Starzl 41 in 1960 as well as 
others,1 6 Starzl, who pioneered liver transplantation, both 
in laboratory and the clinical setting, was responsible for 
establishing this procedure (transplantation) as a viable 
method of treatment of end stage liver disease. 
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The other large animal that was used 
was 
in the study of 
the pig.23 The techniques of liver transplantation 
first report of experimental orthotopic liver 
transplantation in the pig was by Gaston Cordier and his 
co-workers in 1966 in Paris following earlier (1965) 
preliminary investigations.! Their efforts were rewarded 
with some success after two years. They chose the porcine 
model because of the "relative similarity of the hepatic 
anatomy and the bile ducts, to that of man". They used 
relatively large animals (60 kg.), when compared to current 
practice (25 kg.), in the laboratory setting. In reporting 
transplants in 20 animals, they had only six animals 
surviving more than 24 hours, but this laid the basis for 
continuing with the essential work. 
Experimental work on liver transplantation in the pig 
in the United Kingdom was initiated during 1966 by 
Terblanche165 and soon followed in 1967 by Calne.166 
Extensive experimental studies on the technique of 
transplantation naturally progressed into the first 
hesitant steps in establishing the new science of organ 
preservation. I 
The Cape Town group namely Terblanche, Hickman, Spilg 
and Dent established and refined the orthotopic auto- and 
allograft in the porcine model.2,3,4 
Subsequent to these experiments some researchers used 
a variety of other animal models such as the rat, 
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rabbit, dog and the calf,8,9,29,45 The dog, baboon and pig 
were used in numerous transplants since 1955, but in the 
current literature (since 1985) only the pig and dog 
feature as experimental animalsl4,18,19, with an emphasis 
in recent literature on the use of the dog,6,21,27 
It has been stated that the only real test for 
assessment of any technique in experimental liver 
transplantation is the survival of the recipient,6,42 
A variety of techniques for orthotopic, as well as 
heterotopic liver transplantation, have since been 
described,2,6,32,38 These procedures have been adapted from 
the first pioneering attempts which were five to six hour 
procedures with complicated bypass systems, especially in 
canines, to the latest, 6 where the whole procedure was 
performed in less than two hours with the use of a passive 
porto-jugular venous bypass. Experimental transplantation 
in the pig was extensively described by Calne and others, 
7,14,20,22,42 as well as by Terblanche,2 
A modification of these procedures was described by 
Dent 4 and this method with slight modifications is used in 
the JS Marais laboratory (see chapter 5) Hepatic 
autografting in the pig was described by Hickman in 1977 3 
and this method is extensively used in biochemical studies. 
The first attempt at clinical liver transplantation 
was made by Starzl in 1963 in Denver, followed by single 
attempts in Boston and Paris,27 
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Initial investigations into the question of hepatic 
failure treatment, by liver transplantation, centred on 
heterotopic placement of an auxiliary liver. It was thought 
that host and adjunct liver would act in concert, but this 
was soon shown to be incorrect, when it was found that the 
liver deprived of portal flow would atrophy unless the host 
liver was almost non-functioning or alternatively removed. 
The two main theories suggested 
a. That the liver was deprived of essential nutrients 
or hepatotropic factors or alternatively 
b that the blood supply was insufficient.2 3 
Currently heterotopic placement of livers is only 
considered when it is thought that the patient will not 
withstand orthotopic transplantation44. Recent literature 
shows a strong trend towards orthotopic placement of the 
liver, with recipient hepatectomy, especially in 
experimental work.47 
After the establishment of the technique, the advent 
of cyclosporine A in 1977 represented the next major 
advance.48,49 Preservation time of harvested livers 
(experimentally and clinically ), until very recently, 
remained at a maximum of 10 hours. Occasional anecdotal 
reports stated longer preservation periods.16 A major 
recent advance in this field has been obtained with the 
advent of the UW solution. It is now possible to store 
livers clinically for up to 36 hours with safety, and 
15 
experimentally, in the dog and rat, for up to 72 
hours.45,46,47 These extended preservation periods are not 
possible with the porcine liver, where maximum preservation 
time with 100% transplant success rate is 6 
hours.01p1blt1•ed d1t1(011), n,11 t.(p1r10111 
co1111ic1tio1), 
The effect of preservation or transplantation per se 
or a combination thereof on biochemical homeostasis, as 
influenced by the liver, has however, not been addressed 
adequately. Also, changes in haemostasis, without the 
effects of massive blood transfusions, have not been 





























Liver transplantation is established as an accepted 
treatment modality.26,27 The technical aspects in the human 
have been well documented and few improvements in this field 
can be expected.28,48 
Changes in laboratory data values before, during and 
after liver transplantation are the interactive result of 
donor state, pre-existing disease in the recipient, 
iatrogenic manipulations during anaesthesia, the operative 
procedure, as well as ischaemic and reperfusion damage to 
the liver.83 
Products of excretion such as bilirubin have been used 
as a measure of function both in and ex vivo since the early 
1960's.so Attempts have been made to predict function from 
biochemical data in order to prevent or diagnose primary 
non-function of the grafted organ early. Biochemically 
measured substances includes absolute values of 
electrolytes, enzymes, protein fractions and glucose, as 
well as the metabolism of various substances such as 
indocyanine green and lignocaine. The absolute measurements 
of biochemical parameters are to be preferred to tests of 
metabolism which are invasive and where the substances used 
might be detrimental to an already compromised liver.SI 
In biochemical evaluation of function or damage the 
18 
ideal parameter should be a highly specific and sensitive 
measurable quantity, and results should be available as soon 
as possible to be of clinical value.52 
In order to assess changes in the clinical situation, 
where multiple variables exist, it is necessary to have 
knowledge of the effect of the procedure per se, on the 
basic reference values, that are used. 
19 
CALCIUM. 
Ionised calcium concentration in extra-cellular fluid 
under normal circumstances varies between 0.9 - 1.2 mMol/L. 
Intra-cellular free ionized calcium is maintained at 
0.05-0.2 microMol/L. 
It is clear that the processes responsible for 
maintaining this 104 gradient can only exist in viable 
cells, due to the high energy required for maintenance of 
this gradient. The systems available for calcium transport 
across the plasma membrane differ and are dependent upon the 
tissue type. In the hepatocyte a Na+/ca++ exchange system 
and a ca••-ATP-ase pump are the most important factors in 
the plasma membrane maintaining Ca++ efflux and thus 
intra-cellular calcium homeostasis. Evidence has been 
presented for a vasopressin responsive Ca++ transport 
system. 89 
In the endoplasmic reticulum and mitochondria, Ca++ is 
used in the formation and breakdown of ATP. It is thought 
that most intra-cellular calcium is bound in these two 
systems and that they play the most important part in the 
dynamic regulation of intra-cellular ca•+.90 
The presence of calcium binding proteins in the cytosol 
is well known. The first identified was calmodulin, an 
activator of cyclic nucleotide phospho-diesterase. 
Calmodulin regulates plasma membrane ca++pump activity as 
well as glycogen breakdown through mitochondrial function.89 
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Ionised hypocalcaemia in liver transplantation is seen 
upon reperfusion in association with lowering of pH, 
hyperkalaemia and hypotension and can be prevented by 
administration of calcium chloride.83,87 It is impossible to 
predict how much of calcium given as chloride salt will 
disassociate.as An increased level of ca++ in the cytosol 
has been shown to be toxic.as It is therefore necessary to 
be able to measure the ionised calcium available, before and 
after administration of calcium chloride, in order to 
rationalise doses given. Measurement of ionised calcium is 
performed by an ion-selective electrode which method is 
subject to instrument failure. Nomograms exist whereby 
estimated ionised calcium values can be determined from 
total serum calcium values. The accuracy of calculated 
values for ionised calcium is completely unreliable, not 
only under normal circumstances, but especially in the case 
of liver disease where changes may occur in pH as well as 
albumen and globulin ratios.87,104 
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TOTAL MAGNESIUM. 
It is accepted that magnesium metabolism is regulated 
on the same basis as calcium and that these divalent ions 
compete for the same binding sites,110 This competition also 
accounts for difficulties in measuring ionised magnesium, 
due to the higher affinity of ion-selective electrodes for 
calcium. In a medium containing both ions, under ideal 
circumstances, errors in measuring of one of the ions will 
be compounded by errors in measurement of the other,110 
22 
ACID-BASE METABOLISM 
The concept of acid- base metabolism consists of a 
complex buffer system and the ability to excrete acid or 
base through the kidney or lungs. The status of this system 
is described by pH. Disturbances in acid- base metabolism 
are described as metabolic or respiratory in origin, 
depending on the relative quantities of CO2, HCQ3- and 
organic acids.SB 
Significant derangements in acid- base metabolism are 
frequent in clinical liver transplantation. The occurrence 
of acidosis is ascribed to pre-existing disease, anaesthetic 
management, massive blood transfusion and lactic acid load 
from the grafted liver.84 
pH 
Normal hydrogen ion concentration ((H+))in blood or 
serum is 0.00004mEq/L. (H+] is by convention, due to the 
small numbers, relative to other ions in body fluids, 
expressed as pH. It depicts the antilogarithm of [H•].54 
This conceptual bypass makes statistical interpretation of 
pH values difficult because the mean, standard deviation and 
error are not arithmetic functions. Although some authors 
use pH values directly in statistical applications, (H+) 
should be calculated and used in this respect.55 The 
measurement of pH is part of the "Astrup" and performed 
repetitively as part of routine medical care, both intra-
and postoperative. 
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pH is intimately related to pCOz, HCQ3-; therefore it is 
influenced by changes in respiratory and renal function. 
In practice clinical acid-base disturbances are 
referred to as of metabolic or respiratory origin depending 
on the relative values of COz and HCQ3-. This description is 
expressed in the Henderson-Hasselbalch equation, which deals 
with three variables namely COz, HCQ3- and pH. 
pH= pK(HzC03) + log[HCQ3-] • [HzC03]-l 
In order to assess the value of one of these variables 
properly, the other two must be known. 56 Attempts at 
defining the temporal and spatial occurrence of these 
changes, with a view to preventive treatment have been 
made,84 
In clinical liver transplantation variations in acid-
base status usually exist before the start of 
surgery. The difficulties in management are compounded by 
the magnitude of surgery, effect of anaesthesia per se and 
management of fluid and blood loss. During the anhepatic 
phase metabolic acidosis is a common occurrence due to 
increased lactic acid production (hypoperfusion of 
peripheral tissue) as well as decreased removal (anhepatic 
phase). These effects are demonstrated by a decline in pH 
but it is important that this should be seen as part of a 
complex metabolic situation.75 
The infusion of massive volume of blood during liver 
transplantation has been suggested as one of the causes of 
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the decline in pH. Banked blood contains high levels of 
lactic and pyruvic acid.74 
An important cause of acidosis, which has not been 
evaluated, might be reduced tissue (other than liver) 
perfusion. It was shown in 1959 that in extra-corporeal 
circulation, low tissue perfusion was the main cause for 
development of acidosis and resultant low pH.133 
Postoperative metabolic alkalosis is often seen after 
clinical liver transplantation, especially early in the 
recovery phase. It has been ascribed to various causes such 
as citrate toxicity, nasogastric drainage of acid gastric 
contents, lactate metabolism and excess administration of 
sodium bicarbonate.85,74 
There is controversy in the literature about the use of 
sodium bicarbonate on a routine or prophylactic basis in the 




Bicarbonate plays an extremely important role in 
acid-base equilibrium through bicarbonate-carbonic acid 
buffering. 
HzO + CO2 = HC03- + H+ 
With pH this anion is used in assessment of acid base 
balance, in determining metabolic or respiratory origin or 
existence of alkalosis and acidosis. It is necessary to 
calculate or directly measure bicarbonate to make correct 
deductions regarding acid base status,53 
The administration of sodium bicarbonate was thought to 
be an integral and essential part of the intraoperative 
management of hepatic transplantation for the prevention of 
metabolic acidosis,69 
The metabolic alkalosis seen after liver 
transplantation is thought to arise from the metabolism of 
citrate administered with transfused blood or blood 
products.see Chapter 3: Lactic acid, 
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SODIUM. 
Sodium, with associated anions, including chloride, is 
the most important electrolyte in maintaining plasma 
osmolality. An intracellular shift of sodium or absolute 
loss of sodium will cause major changes in extracellular 
fluid volume. 
Hyponatraemia is more significant in the surgical 
setting than hypernatraemia. The rate of development of 
hyponatraemia is more important than absolute values when 
assessing presenting symptomatology.Bl 
Disturbances in sodium metabolism in liver 
transplantation relate to retention and increase in total 
body sodium with expansion of the total body water component 
in hepatic cirrhosis. This derangement in volume 
homeostasis, relates to adequate fluid management of the 
recipient in the postoperative period. In the transplanted 
liver hepatic volume sensing mechanisms82, will not be 
functioning, due to destruction of afferent pathways during 
the harvesting by transection of relevant vagal nerve 
branches. 
Sodium homeostasis in liver transplantation does not 
appear to present problems in relation to intra- or 
postoperative management of recipients. 
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POTASSIUM. 
Potassium, with sodium, is an essential electrolyte in 
normal homeostasis, Normal osmolality of body fluids depends 
on both ions, which is in constant flux, Any change in one 
of these will cause reciprocal changes in other ions to 
maintain osmotic as well as ionic balance. Potassium is 
mainly an intra-cellular cation, Hydrogen ion and potassium 
compete in the renal tubule and therefore direct correlation 
between them exists. Hyperkalaemia in the extra-cellular 
fluid will increase metabolic acidosis and hypokalaemia 
metabolic alkalosis,73 
Hypokalaemia might present late in liver transplanted 
patients in association with metabolic alkalosis following 
massive blood transfusion,74 
Hyperkalaemia is a significant event in liver 
transplantation and is most often seen immediately following 
revascularisation; it is thought to be caused by a 
combination of washout of metabolic by-products from the 
ischaemic liver and residual preservation solution. This 
period is the most unstable phase of transplantation 
characterised by hypotension, bradycardia and dysrythmia,86 
Existing hyperkalaemia in the hepato-renal syndrome, 
with reduced capacity of potassium excretion, will be 
further aggravated by metabolic acidosis,57 
Hyperkalaemia, in the presence of hypocalcaemia, 
28 
might cause cardiac arrest. It is thought to play a major 
role in the post-reperfusion syndrome.72 Potassium changes 
in liver transplantation should not be seen in isolation, 
but as part of a complex metabolic system.57 
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LIVER FUNCTION TESTS 
SERUM ENZYMES. 
Serum aspartate- (A.S.T) and alanine (A.L.T) amino 
transferases as well as lactate dehydrogenase (L.D.H) are 
enzymes that occur naturally in blood in a normal 
distribution with established normal values. !so-enzymes 
have been measured to differentiate the cellular origin of 
these enzymes and are used in clinical biochemistry. 
A.S.T and A.L.T are widely used as indicators of 
cellular damage, both in myocardial and hepato-cellular 
assessment.52 Lactate dehydrogenase, with A.L.T and A.S.T, 
is extensively used in ex vivo studies of liver 
preservation, as a marker of preservation quality. 59 Levels 
of these enzymes are used as markers of damage and function 
of transplanted livers in experimental as well as clinical 
transplantation.45,46,47,48 
A.S.T. occurs in cytoplasm and mitochondria, whereas 
A.L.T and L,D.H are found exclusively in cytoplasm. A.S.T 
release in serum is an indicator of mitochondrial damage, 
whilst A.L.T and L.D.H indicate cellular membrane 
disruption.so The sensitivity of enzyme release is high but 
lacks specificity, even when iso-enzyme determinations are 
done. 52 The use of ratios of A.S.T and A.L.T has been 
advocated as more sensitive and specific in determining 
cellular damage, but is still of questionable value.61 
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Lactate dehydrogenase is even more non-specific than 
A.S.T or A.L.T, but is extensively used as an indicator of 
cellular damage in ex vivo studies. It is rarely used in 
assessment of hepato-cellular damage but the iso-enzymes of 
muscular and cardiac origin are used to assess damage in 
these two organ systems. 
Glutathione S-transferase is a more sensitive indicator 
of hepatocyte damage in chronic active hepatitis than 
absolute values or ratios of any other enzymes. It has been 
suggested that this enzyme is more specific and quantitative 
of hepatocyte damage than aspartate aminotransferase.62 
Alkaline phosphatase is also used as an indicator in 
hepatobiliary disease, but more so as a measure of hepatic 
excretory function. Levels of this enzyme rise earlier than 
those of bilirubin (more 
obstructed before this is 
than 50% of ducts must be 
elevated) in obstructive 
hepatocanalicular disease.63 The enzyme is actively secreted 
from hepatocyte canalicular membranes of obstructed bile 
ducts.64 It is not used as an indicator of preservation or 
reperfusion damage in clinical transplantation but is used 
as an early warning sign in grafted liver rejection.78 
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TOTAL PROTEIN. 
The term includes all proteins found in serum such as 
albumen, alpha and beta globulins as well as a variety of 
carrier proteins. Fibrinogen is an important protein 
manufactured in the liver and is included in the concept of 
total protein.128 
Total protein in the context of surgical patients is 
mainly used to assess nutritional status.130 
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ALBUMEN. 
Albumen is used as an indicator of liver function 
especially in end stage liver disease. Intravascular 
concentration is an important criterion in selection of 
liver transplant recipients.141 
Although the liver is the sole source of albumen, 
plasma concentration or total body albumen pool is not 
always diminished in advanced liver disease. A distribution 
change, where the extravascular pool contains a 
proportionally higher level of albumen relative to the 
intravascular concentration, might also exist in the 
presence of ascites.128 
Albumen plays an important role in the maintenance of 
oncotic pressure and is also a ready source of calories.54 
A very important protective mechanism in albumen 
synthesis and catabolism is the concept of fractional 
catabolic rate. This means that reduced rate of synthesis is 
met by a reduced rate of catabolism to protect the available 
and/or whole body pool of albumen. This mechanism does not 
exist in the case of fibrinogen and is inverted in the case 
of carrier proteins such as haptoglobin. The site of albumen 
breakdown is uncertain and factors controlling synthesis are 
not fully clarified either.128 
Transient hypoalbumenaemia in surgical patients is a 
common but ill understood phenomenon. It usually occurs 
between 5 and 9 days postoperatively and is thought to be 
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caused by retention of albumen in an extra, created 
compartment namely the surgical wound.1 6 1 In rabbits 
transient sequestration of albumen in the wound site has 
been shown.138 In newborn infants with gastroschisis, actual 
loss of albumen, similar to that seen in burn wound sites, 
is seen.139 In renal transplant patients with normal liver 
function hypoalbumenaemia also occurs, although only after 
10 to 14 days, postoperatively. It was postulated that loss 
of albumen through lymphatic channels was responsible for 
this reversible phenomenon.140 An immediate decrease in 
albumen, upon reperfusion, was reported in recipients of 
longterm (72 hour) preserved canine liver transplants.46 In 
these animals albumen concentration did not show any sign of 
recovery during ten postoperative days, but fibrinogen 
concentration, which was also markedly decreased 
simultaneously on reperfusion, returned to normal levels 
within two to three days. 
In the transplant setting the possible hepatotoxic 
effect of immunosuppressive drugs might suppress albumen 
synthesis and worsen existing hypoalbumenaemia. 
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GLUCOSE 
The liver plays a central role in glucose metabolism 
via the reversible process of glycogenesis. Although glucose 
is only one of the glycogenic substances that can be used in 
the liver, it plays a pivotal role in energy metabolism. 65 
Glucose uptake in the liver depends to a large extent 
on blood glucose level, but is influenced by hormonal action 
such as insulin, growth hormone, glucocorticoids, 
epinephrine and glucagon.54 
Various other tissues such as muscle play a major role 
in glucose metabolism, but the effect of these in liver 
transplantation is negligible.65,67,68) 
The liver is the most important site for 
gluconeogenesis because of the presence of 
glucose-6-phosphatase. Production of glucose in sites other 
than the liver can be ignored. Also, metabolism of lactate 
through the Cori (glucose-lactate) cycle takes place 
exclusively in the liver,67,68 This process, as in the case 
of pyruvate, does not produce net glucose gain. It is, 
however, extremely important in glucose homeostasis, and 
even more so during anaerobic glycolysis, to remove excess 
lactic acid by conversion to CO2 through glucose and nett 
gain of energy. The liver is the major site for the citric 
acid cycle in metabolism of pyruvate formed during anaerobic 
glycolysis in all tissue, although this can occur in all 
mitochondria.65 
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Hypoglycaemia is a theoretical possibility during the 
anhepatic phase in liver transplantation, when the only 
source of glucose-6-phosphate (liver) is absent, It was 
suggested that glucose containing solutions be infused 
during the procedure to prevent this condition,69, 
This concept was challenged by a proposition that 
infused glucose might add to the glucose load given during 
massive transfusion with development of a hyperglycaemic 
(hyperosmolar) state in the postreperfusion period,70 
Hyperglycemia has been shown to occur commonly after 
liver transplantation, and it has been suggested that 
glucose was released from the reperfused liver while infused 
glucose attributed nothing to observed hyperglycaemia. 
Underutilisation of glucose due to unrecognised hypothermia 
might also lead to increased blood levels,71 
The role of the transplanted liver in changes relating 
to glucose homeostasis, during and after reperfusion, has 
not been clarified. 
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LACTIC ACID. 
In patients considered for liver transplantation, end 
stage liver disease is the cause of multiple metabolic 
derangements, amongst which is a varying degree of lactic 
acidosis.75 The formation of serum lactic acid under normal 
circumstances occurs because of anaerobic glycolysis, of 
which there is always some degree, resulting in a normal 
level in humans of ±2 mMol/L. Lactic acid is produced by 
muscle, skin, gut, brain and erythrocytes. Excess lactic 
acid is removed by the liver through gluconeogenesis in the 
Cori cycle. The kidney can also excrete excess lactic acid 
but functions mainly as a "backup" system.76 
It has been shown that after low flow states and 
haemorrhage, up to 90% of lactic acid removal is effected by 
the liver, and lactic acid blood levels as well as rate of 
decline thereof, have been used in the prediction of 
survival after occurrence of low flow states. Liver function 
therefore is a major modifier in the regulation and 
evaluation of blood lactic acid levels.77 
During storage of the donor liver anaerobic metabolism 
continues and it is likely that lactic acid is formed in the 
stored liver. 78 In the liver transplant patient, circulating 
lactic acid is increased as part of the disease process 
necessitating transplantation, as well as lactic acid 
flushed out of the liver upon reperfusion. 
The concept of "lactate washout" indicates a 
paradoxical increase in lactic acid concentration after 
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restoration of flow. The duration of this phenomenon after 
liver transplantation has not been established. It has been 
shown in pigs with normal liver function, after controlled 
cardiac arrest and reflow, that this time period was less 
than two minutes and that the rate of decrease in lactic 
acid concentration correlated with survival.so 
Anaesthesia in patients with hepatic failure may cause 
a rise in lactic acid by interference with the hyperdynamic 
state.75 In this quoted study it has been shown that 
anaesthesia abolishes the hyperdynamic state, causing 
hypoperfusion of peripheral tissue with resultant local 
tissue hypoxia, and an increase in lactic acid levels, both 
pre- and post-perfusion of the transplanted liver. The 
resultant metabolic acidosis can further impair hepatic 
clearance of lactates.87 
In the experimental model the complexities of 
preexisting hepatic disease are excluded and anaesthesia is 
standardised; the effect of storage and transplantation on 
lactic acid metabolism can thus be evaluated. 
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CHAPTER ' 4. 
COAGULATION IN 
LIVER TRANSPLANTATION 
A discussion of the theoretical basis of the clotting 
mechanism and the effect of liver transplantation upon 
derangements thereof. Specific reference is made to heparin. 
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COAGULATION a.n.d HEPARIN. 
Haemostasis is the state in the living animal where 
coagulation and thrombolysis are in equilibrium. Coagulation 
consists of a series of linked proteolytic enzymatic 
reactions with the aim of converting fibrinogen into fibrin 
monomers by the action of thrombin. It is an ongoing process 
with built in regulation as will be referred to later. The 
possible mechanism had been postulated by Moravitz in 1905 
but definite proof of its existence was only supplied by 
Seegers in 1940,105 
The concept of the "cascade" mechanism was established 
in 1964 by two separate groups.91,92 Numerous new 
components, as well as hitherto unknown, but postulated 
substances in the coagulation process, have been identified. 
The integral role of platelets and the importance of the 
platelet release reaction, through various factors released, 
is well accepted. 93 The basic mechanism is an extremely 
complex sequence of biochemical events, with inherent 
positive and negative feedback systems. The role of various 
co-factors such as ca++, Factor V, Factor VII, prekallikrein 
and HMW kininogens complicates the understanding of the 
molecular events, at which levels the basic process of 
coagulation and its control, takes place. The waterfall 
concept consists of an extrinsic and intrinsic pathway 
cascading down onto a common pathway ending with the 
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formation of fibrin. This mechanism is in dynamic flux at 
all times. 
The intrinsic mechanism is initiated by the interaction 
of Factor XII with a negatively charged surface to form F 
XIIa. The hepatocyte is the only source of Factor XII.94 
Activated F XII proteolyses Factor IX in a two step reaction 
to F IXa. This step is absolutely quantitatively dependent 
upon Ca++, although Mg++ may be utilised in the absence of 
ca••. When Mg++ acts as a co-factor, the activation rate is 
slower. Excess Mg++ may competitively inhibit the action of 
Ca++, resulting in a decreased clotting activity.95 
The extrinsic mechanism is initiated by tissue factor 
(TF) which has to be released from damaged tissue. Sources 
are monocytes activated by endotoxin, antigen-antibody 
complexes and products of complement activation, as well as 
the platelet release reaction. Tissue factor consists of 
lipoprotein:phospholipid complex in a ratio of less than 
1:450 with an average MW of 43000. This ratio is essential 
to ensure maximal activation of Factor VII. Factor VII is an 
obligatory co-factor for TF.96 
A common pathway exists for the conversion of Factor X 
to F Xa, which is the prothrombin converting serine 
protease. Conversion of F X can only take place on the 
platelet surface. The rate of this reaction is 
dependent on the presence of Factor VIII. F VIII increases 
the velocity of F X formation 200,000 times by aligning F X 
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on the platelet surface for maximum exposure of binding 
sites. Thrombin will then in complex concert with Factor V 
act upon fibrinogen to form fibrin.97 
Haemostasis during and after liver transplantation is 
of the utmost importance in the clinical setting. Patients 
undergoing liver transplantation may have grossly deranged 
haemostatic profiles, which is most often the result of 
pre-existing liver disease.98 Surgical bleeding from 
inadequate haemostasis during dissection, in the portal 
hypertensive patient, may start a consumption coagulopathy 
that will lead to uncontrollable bleeding when the replaced 
liver can not immediately supply essential clotting 
factors.99 
In early clinical and experimental liver 
transplantation heparin was used systemically in the 
recipient, as well as in preservation fluids, with complete 
absence of clotting ability on reperfusion: Although heparin 
is not used routinely during clinical hepatic 
transplantation currently, even with the use of veno-venous 
bypass, enough heparin might enter the circulation, through 
flushing of monitor and access lines, to cause heparin 
intolerance.ss,100 The role of "endogenous" heparin has not 
yet been clarified and this or so called "heparin like" 
substances may play a role in the bleeding tendency of some 
patients.101 
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The role of heparin in bleeding after liver 
transplantation has recently been studied and it was 
concluded that, although not directly responsible, the 
administration of heparin together with dissection and 
handling of the liver may precipitate thrombolysis.153 
Hypercoagulability of blood may also complicate this 
picture, especially where surgery is performed in the 
presence of hepatic tumours.102 This phenomenon may be 
implicated in the pathology of hepatic artery thrombosis, 
but should not have an influence in the experimental 
situation where young healthy animals are used.103 
Thus it can be postulated that in experimental liver 
transplantation, if standardised minimal heparin dosages are 
used in healthy animals, the changes seen in haemostatic 




TECHNIQUE OF PORCINE 
LIVER TRANSPLANTATION. 
A detailed description of the technique, for harvesting 
and transplantation, of the pig liver, is presented. The 
novel technique of autotransplantation developed in this 
laboratory by Hickman is discussed. 
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TECHNIQUE IN THE PIG. 
The method of harvesting and transplantation of the 
liver was largely an adaptation of the techniques described 
by Terblanche, Hickman and Dent 2,3,4. All animals in all 
groups were treated in exactly the same fashion to ensure 
that a uniform approach was applied. 
DONOR OPERATION. 
Young pigs of either sex weighing between 20 and 30 kg 
were starved for 24 hours, but had free access to water. 
Anaesthesia was induced with sodium pentothal (2-3 mg/kg) 
into an ear vein. An endotracheal tube of adequate size was 
inserted and 02 and N2 0 used by intermittent positive 
pressure ventilation at 25 cm H20 to maintain anaesthesia. 
Halothane was not used at all. A 3.5 to 4 cm longitudinal 
incision parallel to the posterior border of 
M.Sternocleidomastoideus was made to approach the external 
or internal jugular vein for insertion of an intravenous 
line to administer 500ml 10% dextrose in balanced salt 
solution (Maintelyte !_)fable 
harvesting procedure. 
solution during the 
A long midline incision was made from xiphisternum to+ 
4 cm above the symphisis pubis using cutting diathermy. A 
self retaining retractor (Balfour) was positioned. The small 
and large bowel were placed in a plastic bag. 
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The right and left coronary ligaments of the liver were 
divided by diathermy. The left lobe of the liver was 
retracted to the right, and the left triangular ligament 
also divided. 
With downward traction on the greater curve of the 
stomach the gastro-hepatic ligament was displayed, The bile 
duct was identified and with sharp dissection this was 
separated from the posteriorly situated portal vein; care 
was taken not to disrupt the loose areolar tissue around the 
bile duct,5 The anterior peritoneal leaf of the 
gastro-hepatic ligament was picked up to the left of the 
bile duct and divided cranially and to the left. The left 
gastric artery was now clearly visible and was ligated and 
divided. The posterior leaf of the gastro-hepatic ligament 
was now divided caudally down to the origin of the coeliac 
axis. The hepatic artery was usually surrounded by lymph 
nodes in this region but could be demonstrated easily, All 
small branches to lymph nodes were carefully cauterised, 
taking care not to damage the hepatic artery proper, and 
lymphadenectomy was performed. During this dissection the 
origin of the gastro-duodenal artery from the right was 
usually easily noticed. This artery was carefully tied about 
3 mm from the hepatic artery, The hepatic artery was 
separated from the portal vein to the origin of the splenic 
artery, 
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The portal vein was now approached from the right and 
dissected free. The pancreatic vein, which was usually 
easily visible just above the upper border of the pancreas, 
draining into the anterior aspect of the portal vein was 
ligated and divided. In autograft procedures this vein was 
always preserved. 
The right lobe of the liver was now gently retracted to 
the left to display the infrahepatic vena cava. A double 
layer of peritoneum, extending from proximal to the adrenals 
glands up towards the diaphragm, and from the inferior vena 
cava to posterior abdominal wall, was divided by diathermy. 
At this stage 5Qu/ks of sodium heparin was given 
intravenously. The common bile duct was transected as distal 
as possible. After a minimum time delay of 4 minutes ( 
circulation time for heparin distribution) an 18F catheter 
was inserted into the portal vein in experiments where a 
flush was indicated. Otherwise a vascular clamp was placed 
at the level of the superior border of the pancreas. In 
rapid sequence the hepatic artery was clamped as proximal as 
possible and transected. A curved vascular clamp was placed 
on the infrahepatic vena cava at the level of the adrenal 
glands. A large curved (Satinsky) vascular clamp was placed 
as far cranially as possible on the suprahepatic vena cava 
including diaphragm and the vena cava was cut on the 
junction with the diaphragm. 
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The infrahepatic vena cava was now transected on the 
clamp and the flushing of the liver immediately started 
through the portal vein catheter. The liver was removed from 
the abdominal cavity and flushing completed. In all cases 
the total volume of flush solution was 1000 ml. 
In the autograft groups this technique was modified in 
the sense that all transections were done at convenient 
midway points. Special attention was given to preservation 
of the pancreatic vein draining into the portal vein, Also, 
the hepatic artery was transected distal to the 
gastroduodenal artery, rather than more proximal as in the 




Dissection in the neck was similar as in the donor, 
except that a catheter was placed in the common carotid 
artery for monitoring of the systolic blood pressure, The 
intravenous central line was always put into the internal 
jugular vein, This line was advanced into the suprahepatic 
vena cava for sampling of hepatic venous effluent during the 
reperfusion of the transplanted liver,167 At the end of the 
procedure this catheter was replaced as an internal jugular 
central line. The external jugular vein was dissected free 
for a distance of 2-3 cm to be used in the spleno-jugular 
shuntCvide infra), 
The approach and dissection for recipient hepatectomy 
was performed in the same manner as in the donor. The 
pancreatic vein was always preserved and the portal vein 
transected as close to the porta hepatis as possible. 
When the liver was completely skeletonised a modified 
highly selective vagotomy was performed in the following 
fashion. The stomach was put under traction caudally and to 
the right, by grasping the greater curve on the gastric 
tube, to display the nerve of Latarjet. The peritoneum was 
picked up at the level of the incisura and divided along the 
lesser curve to the level of the gastro-oesophageal 
junction. Anterior highly selective vagotomy was performed 
by ligation and sharp division. The lesser sac was now 
entered through the gastro-colic ligament and a posterior 







"PARACHUTING" OF DONOR LIVER 
Sodium heparin (25U/ks) was administered and a passive 
spleno-jugular shunt inserted as follows. The splenic vein 
was isolated at the point where it emerges posterior to the 
pancreas and through a transverse venotomy a 18F silastic 
catheter placed and secured by 2/0 cotton ligatures. A 
T-connection to a lL bag with 0.9% saline and the external 
jugular vein was set up. Free flow was observed through this 
venous shunt with an open portal vein, Only then were all 
vessels clamped seriatim starting with the hepatic artery, 
followed by portal vein, infrahepatic inferior vena cava and 
lastly the subdiaphragmatic vena cava; transection of the 
vessels was performed in the same sequence. All vessels and 
ducts were cut in a mirror image fashion to those in the 
donor operation. 
After removal of the liver the abdominal cavity was 
inspected for any bleeding points and if present, these were 
controlled by ligation or cautery. The replacement liver was 
now positioned and the suprahepatic vena cava sutures (5/0 
polypropylene) placed in a "U" fashion.• 11 Dittrn opposite 
Pllt , 
The liver was then "parachuted" into position, This 
method of suture placement ensured that no corner leakage 
occurred in any case as well as endothelium to endothelium 
anastomosis, The posterior wall was sutured from inside 
followed by the anterior wall, 111 Diap11 The portal 
anastomosis was now performed with exactly the same method 
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but utilising 6/0 suture material. The spleno-jugular shunt 
was clamped and the portal clamp released to allow portal 
venous reperfusion. The liver was allowed to fill with blood 
and ~30 ml blood allowed to escape from the lower inferior 
vena cava before it was clamped. 
The clamp on the suprahepatic vena cava was released 
and the effluent of blood controlled over a period of 5-10 
seconds to prevent a sudden rush of hyperkalaemic blood into 
the systemic circulation. The clamp was then completely 
removed. The infrahepatic vena cava anastomosis was now 
performed with 5/0 polypropylene thread. The proximal of the 
two clamps was removed first to vent the small amount of air 
(less than 1 ml), that was usually present in this venous 
segment. 
The hepatic arterial segments were trimmed to ensure 
that there were neither excess vessel nor anastomotic 
tension and the anastomosis performed with continuous 7/0 
polypropylene suture. The shunt catheter was removed from 
the splenic vein and this repaired with 6/0 polypropylene. 
End to end anastomosis of the bile duct was effected with 
the same suture material. 
A final inspection of the abdominal cavity was done to 
establish that there was adequate haemostasis. Mass two 
layer closure of the abdominal wall was effected with 1 
chromic and 2/0 nylon sutures respectively. 
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CHAPTER 6. 
MATERIALS AND METHODS. 
6.1. Groups 
Autograft without flushing. 
Autograft with flushing. 
Coldstorage with Collins solution 
Coldstorage with U.W. solution. 
Coldstorage without any solution. 
6.2. Management of animals. 
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TABLE 1. I q • l f 
~Collins C3 solution. 
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This solution did not contain any heparin, 
Components 5, 6 and 7 were added immediately before use. 
TABLE 2. I 
~University of Wisconsin solution.~ 
Hydroxy-ethyl-starch (Pentafraction) 
Lactobionic acid 
Potassium phosphate monobasic 







Water for injection 
Additions prior to use: 
Dexamethasone 16 mg/L 
Insulin 40 U/L 
Co-trimoxasole 5 ml/L 
























q.s.}pH to 7.4 
Volume to 1000 ml. 
6.1 GROUPS. 
5 Groups of animals were used as follows. 
Autograft without flushing. 
(Group 1) 
In six animals the livers were completely 
dissected free, all the relevant vessels as well as the bile 
duct were transected and the liver removed out of the 
abdominal cavity and immediately re implanted. 
Autograft with flushing. 
(Group 2) 
In seven animals the liver was dissected free, the 
portal vein cannulated, all relevant vessels and bile duct 
transected, the liver removed and flushed ex situ with one 
litre of lactated Ringers solution at 40c, The liver was 
immediately re-implanted. 
Allograft coldstorage with Collins solution. 
(Group 3) 
In seven animals transplantation was performed 
with a liver flushed through the portal vein (cannulated in 
situ), immediately after removal with one litre of modified 
Collins CJ solution (no heparin) (Table 1) at 40c and stored 
in a plastic bag, containing one litre of the same, in an 
outer plastic bag containing one litre of lactated Ringers 
solution, on crushed ice for six hours. 
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Allograft after coldstorage with U.W. solution. 
(Group 4) 
In seven animals transplantation was performed 
with a liver flushed through the portal vein (cannulated in 
situ), immediately after removal with one litre of 
University of Wisconsin solution Table 2 at 40c and stored 
in a plastic bag, containing one litre of the same, in an 
outer plastic bag containing one litre of lactated Ringers 
solution, on crushed ice for six hours. 
Allograft after coldstorage without flushing. 
(Group 5) 
In five animals transplantation was performed with 
a liver harvested and stored on crushed ice for six hours. 
The liver was dissected free, removed and put into a double 
plastic bag. The inner bag contained only the liver whilst 
the outer bag contained one litre of lactated Ringers 
solution to prevent direct contact of the liver with the 
crushed ice. 
No liver, in any of the groups, was flushed out with 
any type of solution prior to reperfusion, except the 
controlled escape of ~30ml blood as described.chapter 3: 
Technique in recipient, 
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6.2 MANAGEMENT OF RECIPIENTS. 
(INTRA AND POSTOPERATIVE) 
An infusion of Maintelyte ~ was started as soon as the 
intravenous line had been inserted. This was run at lml/min 
during the entire procedure. A 4.5% solution of NaCH03- was 
set up to administer 25 mEq of NaCH03- during the anhepatic 
phase. The spleno-jugular shunt was very slowly infused with 
0.9% NaCl solution at 3-5 drops (10 drops per ml) per 
minute. The total volume of crystalloid fluid amounted to 
~500 ml during the first six hours. Another 1500 ml 
Maintelyte R was given in the first 24 hours to a total of 
2000 ml. 
Sampling for the following determinations was done. 
1. Blood for pH, pC02, p02, HC03-, Base excess, Na+ and 
2, Activated clotting time on whole blood, 
3. Serum aspartate and alanine transaminases. 
3. Serum lactates. 
4. Serum bilirubin, 
5. Full clotting profile. 
6. Total and ionised calcium. 
7. Total magnesium. 
8. A biopsy of about 2 gm of liver tissue for tissue 
calcium determination, 
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The sampling schedule was as follows, 
1. Pre-hepatectomy, At± 10 minutes after initiation of 
intermittent positive pressure ventilation, 
2, Five minutes after restitution of portal flow. At 
this point the liver had been perfused with mesenteric 
venous blood for~ 5 minutes. 
3. Five minutes after restitution of vena cava flow • 
. The pooled blood from the lower systemic circulation (legs 
and renal) was back into circulation. 
4. Five minutes after hepatic arterial anastomosis 
(full hepatic revascularisation ), 
5. Thirty minutes after full revascularisation. 
6. Six hours after full revascularisation. 
7. A total of 26 ml of blood was taken daily for 
biochemical analysis for 7 days as set out. Vide supra 
At time points 1 through 5, samples were obtained from 
the hepatic vein catheter for determinations 1, 6 and 7. 
See: Chapter 6: Saapling schedule, In group 1 this was not 
done at all and in groups 2 and 3 in only three animals in 
each group. 
It should be noted that the actual time between 
sampling points was more than Five minutes; Timepoint (TP) 1 
at 10 minutes into the operation, TP 2 at ±40 minutes, TP 3 
at ±50 and TP 4 at± 90 minutes after starting anaesthesia. 
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No blood or plasma was given at any point during the 
procedure, Co-trimoxasole (5ml) was given in the first litre 
of Maintelyte ~ and daily thereafter for three days. No 
liver was flushed prior to being revascularised. During the 
second 24 hours after transplantation, 1 litre of Maintelyte 
~ was given, No parenteral fluid was given after the second 
day. 




7.1 SURVIVAL OF ANIMALS. 
7.2 BLOOD AND SERUM MEASUREMENTS 
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7.1 SURVIVAL OF ANIMALS. 
Six animals in each group survived for seven or more 
days. The simple cold storage allograft and Ringer lactate 
flushed autograft groups had six consecutive survivors. In 
all recipient animals total operating time was less than 
ll/2 hours. Operating time in autograft procedures was 
comparable to that in the allografted animals. Recipient 
hepatectomy on average took 15 minutes whilst highly 
selective vagotomy and placement of the spleno-jugular shunt 
required 10 to 12 minutes. Anhepatic time (until restoration 
of portal flow) was always less than 15 minutes, Arterial 
anastomoses and splenic vein repair were always performed 
with magnification. The same sequence of anastomosis was 
used in all transplants. 
No technical failure occurred. There were no 
incidences of gastric ulceration, Hepatic artery thrombosis 
did not occur. Pigs that died before seven days ( three ) 
did not have a discernible cause but metabolic parameters 
indicated non function of the grafted liver. All animals 
that died were in severe irreversible metabolic acidosis, 
with low bicarbonate and high lactic acid levels. 
Haemorrhage was not a cause of death in these pigs, nor did 
any coagulopathy occur. 
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7.2 BLOOD AND SERUM MEASUREMENTS. 
In description of the changes occurring in laboratory 
data extensive use will be made of reference sampling points 
designated as TP (timepoints). For convenience sake an 
abbreviated key is presented as a footnote on each page that 
contains descriptions relating to changes in laboratory 
values at timepoints. The full description is as follows. 
Characters in parentheses are those used in graphs to 
describe timepoints on the X-axis. 
TP 1 (PRE,) This is also referred to as baseline value. 
Pre-hepatectomy, At + 10 minutes after initiation of 
intermittent positive pressure ventilation. 
TP 2 (5'P,V.) Five minutes after restitution of portal 
flow. At this point the liver had been perfused with 
mesenteric venous blood for five minutes. 
TP 3 (5'I.V.C.) Five minutes after restitution of 
infrahepatic inferior vena cava flow. The pooled blood from 
the lower systemic circulation (legs and renal) was back 
into circulation. 
TP 4 (5'H.A.) Five minutes after opening hepatic 
arterial anastomosis (hepatic revascularisation). 
TP 5 (30'Revas) Thirty minutes after full 
revascularisation. 
TP 6 (6 HR) 6 hours after full revascularisation. 
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Day 1-6. Refers to postoperative day. Day 1 denotes 24 
hours after transplant. 
Following description of changes in each measured 
parameter, a graphic representation of changes in autograft 
and allograft groups will be presented. The X-axis 
represents time. It needs to be noted that the reference 
points on the X-axis are not to scale, but are presented in 
this manner to highlight the acute changes that do take 
place early in the procedure, during and following 
revascularisation. 
All results were subjected to statistical evaluation by 
means of Student's t-test, both in groups with reference to 
baseline values and between groups at comparable timepoints. 
All statistically significant differences (by t-test) were 
also subjected to non-parametric evaluation before being 
reported as significantly different. Statistical 
calculations were done by hand, by the author utilising a 
Hewlett-Packard Cll scientific calculator. Differences 
between mean values with a p-value of< 0.05 were regarded 
as statistically significant. 
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CHAPTER 8. 
CHANGES IN BIOCHEMICAL VALUES. 
8.1. Calcium. 
8.2. Magnesium. 



























Pre 5'P.V 5'1.V.C 5 'H.A 30'Revas 6 HR D1 D2 
TIME POINT 
o-o 1: NO FLUSH(n:6) • - • 2: RINGERS(n:6) 
TOTAL CALC IUM 









' & 2.000 l 
1.800 -+----+---+---+---+---+---+---+---+---+---
Pre 5'P.V 5' 1. V.C 5'H.A 30'Revos 6 HR D1 D2 D3 
TIME POINT 
• - • 3 : COLLINS(n:6) .& - .& 4: U.W.(n:6) • - • 5: S.C.S(n:5) 
* COMPARED TO PREVALUE IN CROUP ** COMPARED TO OTHER GROUPS AT TIMEPOINT. 
8.1 TOTAL CALCIUM. 
Arterial: Fig.1. 
Mean baseline values in 4 groups (1,2,3 and 5) lay 
between 2.34~0.12 and 2.52~0.12 mmol/L. Only in group 4 
(storage in UW solution) was the mean baseline value lower 
at 2.20~0.23. This difference was not statistically 
significant and could not be attributed to anything 
specific. There was a decline in calcium in all groups at TP 
2,3 and 4 which was significantly (p<0.05) lower than 
baseline. This represented a fall of 11.3 - 16.8% in various 
groups. 
In group 3 (Collins) by TP 3 and group 5 (S.C.S) by TP 
4, total calcium values had returned to almost normal and 
remained so for the rest of the study. 
In groups 1, 2 and 4 there was a slower return to 
normal, although from TP 5 and 6, the values were not 
significantly reduced. 
TOTAL CALCIUM. 
Venous Not shown 
The concentration of total calcium in all venous 
samples were almost identical to that obtained in arterial 
blood. 
TP-1:PRE, TP-2:5'P.V, TP-3:5'I,V.C. TP-4:5'H,A, 
TP-5:30'Revasc. TP-6:6hrs.revasc, DAY J:Postop. 
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1.000 -+----r-,--t,--+, --t--'--+,--+-, -----1,1----+----+-- -----i 
mMol/L 
Pre S'P.V 5 '1.V.C S'H.A 30'Revas 6 HR D1 D2 D3 
TIME POINT 
o-o NO FLUSH (n.6) • - • RINGERS(n:6) 
IONISED CALCIUM 
ALLOGRAFT 6 HOUR STORAGE 








Pre 5'P .V 5'1.V.C 5'H .A 30'Revas 6 HR 01 02 03 
TIME POINT 
• - ·• COLLINS (n:6) • - • U.W.(n:6) •-• S.C.S{n:5) 
•COMPARED TO PREVALUE IN GROUP ••COMPARED TO OTHER GROUPS AT TIMEPOINT. 
IONISED CALCIUM. 
Arterial: Fig.2. 
Mean baseline arterial values ranged between 1.22L0.17 
and 1.31L0.02 mmol/L in all groups except 4, where values 
were again lower as with total calcium. However, the ratio 
of total to ionised calcium was similar in all groups. 
The pattern of decline of ionised calcium after 
revascularisation occurred in all groups. The return towards 
normal was similar in groups 2, 4 and 5. In group 1, there 
was a continued decline, which was highly significant on day 
2. In group 3, mean values exceeded baseline value at TP 5, 
but then returned to baseline levels. 
IONISED CALCIUM. 
Venous Not shown, 
Baseline values were almost identical to those from 
arterial samples. Values at TP 2 showed the same percentage 
point fall as in arterial samples. Values at time points 3 
to 5 were showing an upward trend to have higher than 
baseline values in groups 2, 3 and 4 at TP 5, although not 
statistically significant. 
TP-1:PRK. TP-2:5'P.V. TP-3:5'I.v.c. TP-4:5'H.A, 





















Pre S'P.V 5'1.V.C 5'H.A 30'Revas 6 HR D1 D2 D3 
TIME POINT 
o - o NO FLUSH (n:6) +- + RINGERS (n:6) 
TOTAL MAGNESIUM 
ALLOGRAFT 6 HOUR STORAGE 
values:v±s.e. 
0 .650 -+-----+---+-----+---+----t---1----+----11----+----1 
Pre S'P.V 5'1.V.C 5'H.A 30'Revas 6 HR D1 D2 D3 
TIME POINT 
• - • COLLINS (n:6) ..t.-..t. U.W.(n:6) • - • S.C.S(n:5) 
• COMPARED 10 PREVALUE IN GROUP .. COMPARED TO OTHER GROUPS AT TIMEPOINT. 
8.2 TOTAL MAGNESIUM. 
Arterial:Fig.3. 
Mean baseline values were within the range 0.77~0.13 to 
0.83~0.07 mmol/L. There were limited increases at TP 2, 3 
and 4 in groups 1, 2, 4 and 5. Thereafter values declined to 
or slightly below baseline. 
In group 3, there was a highly significant increase in 
total magnesium at TP 2, 3, 4 5 and 6, which only returned 
towards baseline on day 2. 
TOTAL MAGNESIUM. 
Venous Not shown 
Values followed exactly the same pattern but actual 
measurements were on average 12% higher than the arterial 
values (statistically significant) in groups 2,4 and 5. In 
group 3, although higher by 6% it was not significant. As in 
arterial samples the peak occurred at TP 2 with a decline 
towards normal levels, but still higher than baseline at TP 
5. 
TP-1:PRE, TP-2:5'P.V. TP-3:5'1.V,C, TP-4:5'H,A. 
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7.200~-----__J 
Pre 5'P.V 5'1.V.C 5'H.A 30'Revos 6 HR D1 D2 D3 D4 
TIME POINT 
o-o NO FLUSH (n:6) • - • RINGERS (n:6) 
pH 






7.200 ............. _......__......_ _ _,__ ____ -+---+-------+---+-----< 
Pre 5'P.V 5'1.V.C 5'H.A 30'Revos 6 HR D1 D2 D3 D4 
TIME POINT 
• - •COLLINS (n:6) •-a.U.W.(n:6) • - •S.C.S(n:5) 
• 
8.3 ACID BASE METABOLISM. 
pH CHANGES. 
Arterial: Fig.4. 
The baseline pH values ranged between 7.37 and 7.44. 
There was a decline of varying degrees between TP 2 and 4 in 
all groups. In groups 1, 3 and 4 this decline continued 
throughout revascularisation, but in groups 2 and 5 the 
levels increased above baseline from TP 4. 
By TP 6 all values had increased to or above baseline 
and remained so for the rest of the study. 
pH CHANGES. 
Venous Not shown. 
All groups had baseline pH values lower than in 
arterial blood, ranging from 7.12 to 7.38. In group 2, 
venous pH, contrary to arterial pH, continued to decline to 
reach lowest level of 7.09 at TP 4. In groups 3, 4 and 5 the 
lowest pH levels, ranging from 7.12 to 7.23 were also 
recorded at TP 4. 
TP-1:PRE. TP-2 :5'P.V. TP-3 :5'I.V.C. TP-4:5'H.A, 
TP-5:30 ' Revasc. TP-6:6brs.revasc. DAY t:Postop. 
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FIG. 5. 
mMol / 1 
PLASMA BICARBONATE 
IM MEDIATE AUTOGRAFT 







Pre 5'P.V 5'1.V.C 5'H.A 30'Ravos 6 HR 01 02 
TIME POINT 
o-o NO FLUSH (n:6) • - • RINGERS (n:6) 
PLASMA BICARBONATE 











Pre 5'P.V 5'1.V.C 5'H.A 30'Revos 6 HR D1 02 03 
TIME POINT 
• - • COLLINS (n:6) A-• U.W.(n:6) • -• S.C.S(n:5) 
• CO~PAAEO TO PREVALUE IN GROUP 
PLASMA BICARBONATE. 
Arterial: Fig.5. 
Bicarbonate values were calculated on a 
Siggaard-Anderson nomogram using pH and pC02 values. All 
determinations were done within minutes on anaerobically 
obtained arterial blood samples. 
Baseline values at TP 1 varied from 20.2 mMol/L in 
group 2 to 25.9 mMol/L in group 5. There was no 
statistically significant difference between groups at this 
TP. 
From TP 3 to TP 5 there was no change in plasma 
bicarbonate of groups 1, 2, 4 and 5; in group 3 there was a 
significant decline to TP 4. Thereafter, in all groups there 
was an increase which persisted to remain above baseline for 
the rest of the study. 
There was a strong association between a rise in serum 
bicarbonate, decline in lactic acid concentration and 
clinical impression of early recovery from anaesthesia as 
well as eventual survival of animals. In the animals that 
did not survive bicarbonate levels remained at low (< 16 
mmol/L) levels after revascularisation until demise after 6 
to 8 hours. 
TP-1 :PRE, TP-2 :5'P.V, TP-3:5 11.v.c. TP-4:5'H.A. 
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Pre 5'P.V 5'1.V.C 5'H.A 30'Revas 6 HR D1 D2 
TIME POINT 
o-o 1: NO FLUSH(n:6) • - • 2: RINGERS(n:6) 
SODIUM 







110 • p<.05 
100 +---+--t----+------t----+--+----t,~--t,- ............... 
Pre 5'P.V 5'1.V.C S'H.A 30'Re..-os 6 HR 01 D2 D3 
TIME POINT 
• - • 3: COLLINS(n:6) • -• 4: U.W.(n:6) • - • 5:S.C.S(n:5) 
• COMPARED TO PREVALUE IN GROUP 
SODIUM. 
Arterial: Fig.6. 
Baseline mean sodium values ranged from 122Ll to 134L6 
mmol/L. Thereafter there was no significant change except in 
group 3, where a significant reduction (p<0.05) occurred 
from TP 1 to TP 4. However, from TP 5 these values were in 
the normal range. 
SODIUM. 
Venous : Not shown 
There was no difference between arterial and venous 
sodium concentration in any group at any time. 
TP-1:PRE. TP-2:S'P.V. TP-3:5'r.v.c. TP-4:5'H.A. 
TP-5:30'Revasc. TP-6:6hrs.revasc. DAY t:Postop. 
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Pre S'P.V 5'1.V.C 5'H.A 30'Revas 6 HR D1 02 03 
TIME POINT 
o-o NO FLUSH (n:6) • - • RINGERS (n:6) 
POTASSIUM 
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2.000 +----+--+-----+--+----+--+--·-+---+----+----; 
Pre 5'P.V 5 '1.V.C 5'H.A 30'Revos 6 HR D1 02 D3 
TIME POINT 
• - • COLLINS (n:6) ... - • U.W.(n:6) • - • S.C.S(n:5) 
• COMPARED TO PREVALUE IN GROUP •• COMPARED TO OTHER GROUPS AT TIMEPOINT. 
POTASSIUM. 
Arterial: Fig.7. 
Potassium values at TP 1 ranged from 3.32LQ,38 to 
3.90L0.12 mEq/L. These values were in the normal range 
accepted in our laboratory. 
A statistically significant mean increase (p<0.05) of 
between 28 and 51% occurred in groups 1, 3, 4 and 5 at TP 2. 
In group 1 concentration increased by 28%, in group 3 by 51% 
and groups 4 and 5 by 38 and 37% respectively, There was no 
difference between groups. 
The mean increase in group 2 at TP 2 was 11%; which was 
not significantly different from group 1, The mean increase 
was, however, significantly lower than that seen in the 
other groups, at this TP, 
From TP 3 all values in all groups were within normal 
range, albeit higher than baseline, In all groups 
potassium values were completely in the normal range and 
remained so for the rest of the study. 
TP-1:PRE, TP-2:5'P.V. TP-3:5'I.V.C, TP-4 :5'H.A, 
TP-5 :30'Revasc. TP-6 :6hrs.revasc. DAY t :Postop. 
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FIG. 8. POTASSIUM 
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* COMPARED TO PREVALUE IN GROUP ** COMPARED TO OTHER GROUPS AT TIMEPOINTS. 
MAGNESIUM 









Pre S'P.V 5'1.V.C 
TIME POINT 
S'H .A 30'Revas 
• - • RINGERS (N:6) • - • COLLINS (N:6) A - A U.W (N:6) • - • S.C.S (N:5) 
POTASSIUM. 
Venous: Fig.8. 
Baseline potassium levels were higher than 
corresponding arterial levels in all groups except group 4, 
where the mean value was 0,18mEq/L (4.3%) lower, None of the 
differences were statistically significant, 
At TP 2 venous potassium concentrations in all groups 
were higher than corresponding arterial levels, 
In groups 2 and 4 the increase in venous K+ was double 
that seen in the arterial K+, Due to small numbers in these 
groups (3 and 2 respectively), statistical evaluation was 
not performed. 
In groups 3 and 5 K+ levels at TP 2 were statistically 
significantly (p<0.01) higher than baseline venous values. 
Although venous K+ values were higher than the corresponding 
arterial concentrations, no statistical significance was 
reached. 
Potassium levels at TP 3, 4 and 5 were higher than 
baseline venous and corresponding arterial levels, but 
statistical significance was not reached in either instance. 
TP-1:PRE. TP-2:5'P.V. TP-3:5'I.v.c. TP-4:5'H.A, 
TP-5:30'Revasc. TP-6:6hrs.revasc, DAY t:Postop. 
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Pre 5'P.V 5 '1.V.C 5'H.A 30'Revas 6 HR D1 D2 D3 
TIME POINT 
o-o 1: NO FLUSH ( n:6) • - •2: RINGERS FLUSH (n:6) 
SERUM A.S.T 
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Pre 5'P.V 5' 1.V.C 5'H.A 30'Revas 6 HR D1 
TIME POINT 
D2 
• l p<.05 
•• 5 
D3 D4 
•-•3: COLLINS (n:6) •-•4: U.W. (n:6) • - •5: S.C.S (n:5) 
• COMPARED TO PREVALUE IN GROUP° COMPARED TO OTHER GROUPS AT TIMEPOINT. 
I I 
8.4 LIVER FUNCTION TESTS. 
ASPARTATE AMINOTRANSFERASE (A.S.T). 
Fig 9. 
The mean preoperative minimum and maximum values ranged 
from 21.3(~4.5) to 30.8(~12.5) units/L. There was no 
significant difference in or between group baseline values. 
In groups 3, 4 and 5 there was a progressive 
statistically significant increase at all timepoints in mean 
plasma AST which reached a peak of 500-700 units/L between 6 
hours and day 1, and declined thereafter. In groups 1 and 2 
the increase was only significant at 6 hours; values had 
returned to the normal range by two days postoperatively. 
Aspartate aminotransferase concentrations at all 
timepoints from 2 to 6, in group 5, were statistically 
significantly (p<0.05) higher than all other groups. 
TP-1:PRE, TP-2:5'P,V. TP-3:5'1,V,C. TP-(:5'H.A, 
TP-5:30'Revasc. TP-6:6hrs.revasc. DAY t:Postop. 
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Pre 5'P.V 5'1.V.C 5'H.A 30'Revas 6 HR D1 D2 03 
TIME POINT 
o-o 1: NO FLUSH (n:6) • - •2: RINGERS (n:6) 
SERUM A.LT 













Pre 5'P.V 5'1.V.C 5'H.A 30'Revos 6 HR 01 02 D3 
TIME POINT 
•-• 3: COLLINS(n:6) •-• 4: U.W. (n:6) •-• 5: S.C.S (n:5) 
ALANINE AMINOTRANSFERASE, 
Fig,10. 
Mean baseline values varied between 20(~10) and 40(~10) 
units/L minimum and maximum respectively, 
There was a mean increase to a maximum of 60 units/Lin 
all groups between TP 4 and day 2, However, due to the wide 
variation in values, there was no significant difference 
from baseline or between groups at any time. 
TP-1:PRE. TP-2:5'P.V. TP-3:5'1.V.C. TP-4:5'H.A. 












NO SIGNIFICANT Dl ffERENCES AT ANY TIMEPOINT 
values:v±s.e. 
0-t-----+----t------t-----+--- -+------+-------l 
S'P.V 5'H.A 6 HR D1 03 05 
TIME POINT 
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5'P.Y S'H .A 6 HR D1 D3 05 
TIME POINT 
• - • 3: COLLINS (n:6) •-•4: U.W. (n:6) • - • 5: S.C.S (n:5) 
• COMPARED TO PREVALUE IN GROUP •• COMPARED TO VALUES IN OTHER GROUPS AT TIMEPOINT. 
ALKALINE PHOSPHATASE. 
Fig.11. 
Determinations were done at TP 1, 2, 4, 6 and days 1, 3 
and 5 and reported as Shinowara-Jones units (S.J). 
There was no difference between mean baseline values of 
any of the groups. 
Only in g+oup 3 was there a significant (p<0.05) 
increase - at TP 5 and on day 1, to baseline and other 
groups peak and/or day 1 values. The maximum values in this 
group were 11.9 (~1.3) and 11.5 (~1.6) S, J units/Lat TP 5 
and day 1 respectively. 
There was a marked decline in mean values in all groups 
after day 1, which reached significance only in groups 2 and 
4 when compared to peak values. Only in group 4 were levels 
at day 5 significantly lower than baseline values. 
TP-1:PRE, TP-2:5'P .V. TP-3:5'1.V,C, TP-(:5'H.A, 










Pre 5'P.V 5'1.V.C 5 'H.A 30'Revas 6 HR D1 D2 D3 
TIME POINT 
o-o 1: NO FLUSH (n:6) •-• 2: RINGERS (n:6) 
TOTAL PROTEIN 
ALLOGRAFT 6 HOUR STORAGE 
Pre 5'P.V 5'1.V.C S'H.A 30'Revas 6 HR D1 
TIME POINT 
values:v±s .e. 
* l p<. 02 
** 5 
D2 03 
• - • 3 : COLLINS (n:6) _. _ _. 4: U.W. (n:6) • - • 5: S.C.S(n:5) 
TOTAL PROTEIN. 
Fig.12. 
Total protein values for all groups at TP 1 ranged from 
55.6(~5) to 61.4(~5.1) gm/L. These differences were not 
significant. There was a slow decline during the operation 
in groups 1 and 2 where the lowest level (20% decrease) was 
seen in group 2 at day 2, In these groups however, values 
returned to baseline by day 3. 
The decline in groups 3 and 5 was significantly sharp 
(p<0.02) immediately after revascularis~tion. In group 4 
there was no significant change although a slight fall was 
noted on day 1. 
In all groups, baseline levels were reached by day 3. 
TP-1:PRE. TP-2:5 ' P.V. TP-3:5'I.v.c. TP-4 :5'H.A. 
TP-5:30'Revasc. TP-6:6hrs.revasc. DAY t:Postop. 
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Pre 5'P.V 5' 1. Y.C S'H.A 30'Revos 6 HR D1 D2 D3 
TIME POINT 
o - o 1: NO FLUSH(n:6) +-+ 2: RINGERS(n:6) 
ALBUMEN 
ALLOGRAFT 6 HOUR STORAGE 
Pre 5'P.V 5'1. V.C 5'H.A 30'Revos 6 HR D1 
TIME POINT 




• -• COLLINS (n:6) • -• U.W.(n:6) • - • S.C.S(n:5) 
$/ * COMPARED TO PREVALUE IN CROUP 
ALBUMEN, 
Fig.13, 
Mean baseline albumen concentration ranged from 
32(~2.7) to 37.4(~2.7) gm/L, 
There was a slow decline in all groups during 
revascularisation, The lowest mean values were reached at TP 
5 (groups 1, 3, 4 and 5) and at TP 6 (group 2), In all 
instances these values were significantly lower than 
baseline (p<0.02), but there was no difference between 
groups, 
In all groups baseline values were reached by day 2, 
TP-1:PRE, TP-2 :5'P.V. TP-3:5'I.V.C. TP-4 :5'H.A. 
TP-5 :30'Revasc. TP-6:6hrs.revasc. DAY t :Postop. 
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o-o 1: NO FLUSH(n:6) • - + 2: RINGERS(n:6) 
mg/d i 
PLASMA GLUCOSE 
ALLOGRAFT 6 HOUR STORAGE 
Pre S'P.V 5'1 .V.C S'H.A .30'Revas 6 HR 01 
TIME POINT 
va lues:v ±s.e. 
D2 D.3 
• - •3: COLLINS(n:6) .t.-.t.4: U.W. (n:6) • - •5: S.C.S (n:5). 
GLUCOSE, 
Fig,14, 
There was a wide range of blood glucose levels at TP 1 
from 150(~24.3) to 250(~82.1) mg/dL, This wide range was 
probably due to the infusion of a 10% dextrose solution 
(MaintelyteR), There was no statistical difference between 
values in the groups. 
In all groups, high levels were sustained until TP 5. 
In group 4, however, levels were significantly (p<0.05) 
lower than those in groups 3 and 5. 
Although glucose containing infusion continued there 
was a significant decline in mean values from TP 5 to day 1, 
Thereafter values remained within the normal range 
regardless of the discontinuation of glucose containing 
infusion, 
TP-1:PRB. TP-2:5'P.V. TP-3:5'I.v.c. TP-4:5'H.A. 
TP-5:30'Revasc. TP-6:6hrs.revasc. DAY t:Postop. 
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ALLOGRAFT 6 HOUR STORAGE 
mMol/L 
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Pre 5'P.V 5 '1.V.C 5'H.A 30'Revas 6 HR D1 D2 
TIME POINT 
•-• 3: COLLINS(n:6) • - • 4: U.W.( n:6) •-• 5: S.C.S.(n:5) 
• COMPARED TO PREVALUE IN CROUP. 
LACTIC ACID, 
Fig,15. 
Mean baseline plasma concentration of lactic acid 
varied between 2,0l(~.46)and 3.2(~.82) mMol/L for all 
groups, 
There was a significant twofold increase upon initial 
reperfusion and a further increase upon opening of the I.V.C 
in all groups: thirty minutes after complete 
revascularisation the levels of lactic acid in allografts 
were still significantly elevated and were different from 
those in autografts (p<0.02), 
By day 1 however, all values were within baseline 
range, There was a strong association between a decline in 
lactic acid concentration, rise in serum bicarbonate and 
clinical impression of early recovery from anaesthesia as 
well as eventual survival of animals. In the animals that 
did not survive, lactic acid levels remained at high (>5 
mmol/L) levels after revascularisation until demise after 6 
to 8 hours. 
Lactic acid in plasma remained between 1 and 2,5 mMol/L 
in all groups from day 1 to 7. 
In summary, a similar pattern was observed in all 
animals, except that in the allograft groups levels remained 
higher for thirty minutes following full revascularisation. 
TP-1:PRE. TP-2 :5'P.V. TP-3 :5'I.v.c. TP-4 :5'H.A. 
TP-5:30'Revasc. TP-6 :6hrs.revasc. DAY t:Postop. 
77 
BILIRUBIN, 
Data not shown, 
Bilirubin concentration did not change from values at 
TP 1 in any of the groups during the first six hours, or for 
the first three days. In some animals a rise in bilirubin 
was evident at day 3. This was not confined to a specific 
group and occurred in about 30% of all animals. 
In half these animals bilirubin rose to a peak at day 5 
or 6, but with marked reductions in concentration over 
subsequent 24 hour periods, to baseline values. 
If a spontaneous decrease did not occur, a continuing 
increase in bilirubin concentration coincided with a 
clinical post-mortem diagnosis of rejection. Choledochal 
anastomoses did not show stricture at post-mortem in any of 
the animals. 
TP-1:PRE, TP-2:5'P.V. TP-3:5 11.v.c. TP-4:5'H.A, 






Partial thromboplastin time. 
Activated clotting time. 
Fibrinogen. 
Platelets. 
Packed cell volume. 
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PROTH ROM Bl N Tl ME 
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values:v± s .e. 
15-.--~~~~~~~~~~~~~~~~~~~~~~~ 
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Fig.16. 
Baseline values at TP 1 varied from 10.5 to 11.5 
seconds in all groups. There was a significant increase in 
all groups at TP 6 and day 1 (p<0.05). This increase 
persisted in group 1 until day 3, but in all other groups 
values at day 3 were not significantly raised. In all groups 
values were back to baseline values by day 4. 
PARTIAL THROMBOPLASTIN TIME. 
Data not shown • 
Baseline values for this test modality were between 
20.5 and 21 seconds. In all groups of animals virtually no 
changes occurred during the procedure or in the first 24 
hours. 
There were no animals with prolonged partial 
thromboplastin times after the first day. In some animals a 
shortening of partial thromboplastin time occurred at day 4 
or later. This did not show any specific pattern and 
occurred in all groups. The changes were not statistically 
significant. 
TP-1 :PRB. TP-2 :5'P.V. TP-3:5'I.V.C. TP-4:5'H.A. 
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Fig.17. 
Baseline activated clotting times (A,C.T,), taken 
before administration of heparin, were between 83 and 92 
seconds. 
The mean times increased in all groups at TP 1 
(p<O.Ol-p<0.02), The peak times were reached between TP 1 
and TP 3. Thereafter all time values declined towards normal 
except in group 3 where values remained prolonged to TP 4. 
Activated clotting times in group 3 were significantly 
prolonged (p<0.02) at TP 3 and 4 both to baseline and all 
other group values. In all groups values were back to 
baseline levels by 6 hours (TP 5), and remained so for the 
duration of the study, 
TP-1:PRE. TP-2:5'P.V. TP-3:5'I.V.C. TP-• :5'H.A. 
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Fig.18. 
Mean baseline values ranged from 189 (L31.6) to 255 
(L30.1) mg/dL. 
In all groups there was a slow decrease in fibrinogen 
concentration during revascularisation (similar to that 
noted for albumen). At TP 5 this decrease was significant 
for group 1 (p<0.002) and group 2 (p<0.05), and at TP 6 for 
groups 3, 4 and 5 (p<0.05). 
There was a sharp increase of fibrinogen concentration 
in all groups between TP 5 and day 1 (p<0.05), and a further 
increase at day 2 (p<0.02 for groups 1 and 2; N.S for other 
groups) when compared to baseline values. These higher (than 
baseline) levels persisted throughout the study. 
Decreases of fibrinogen in both groups followed a 
similar pattern. The major difference was that in allograft 
groups the lowest mean fibrinogen concentration was obtained 
at TP 6 as opposed to TP 5 in autograft groups. 
TP-1 :PRE. TP-2:5'P.V. TP-3:5'r.v.c. TP-4:5'H.A. 
TP-5 :30'Revasc. TP-6:6hrs.revasc. DAY t :Postop. 
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FIG. 19. 
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Fig.19. 
Mean platelet counts in all groups varied from 422(~76) 
to 482(~142) x 103/ml. There were no significant differences 
between any of the groups. 
There was a decline in platelet count to a significant 
lower level in autografted animals (group 1, TP 6 p<0.02; 
group 2, day 2 p<0.05). In group 3 and 5 an immediate 
significant decrease (p<0.05) was seen at TP 2 which 
persisted to TP 6. No immediate change was observed in group 
4, but the decline in this group occurred at day 1. 
There was no difference between groups at given 
timepoints. 
Platelet counts returned towards normal between days 2 
and 3 in all groups. 
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Fig.20. 
Mean baseline packed cell volume in all groups lay 
within a narrow range of 33,l(L2.3) to 35.3(L2.3) ml/dL with 
no difference between groups. 
There was a slow decline in groups 1 and 2 to a mean 
nadir at TP 4 of 18-22% (p<0.02) and this remained so to the 
end of the study. 
In allografts (groups 3, 4 and 5) there were no changes 
until after 6 hours at day 1. In groups 3 and 5 mean values 
on day 1 were significantly lower than baseline (p<0.05). In 
group 4, only the value on day 3 was significantly lower. 
From day 3 to 7, the values in groups 3, 4 and 5 were 
significantly (p<0.05) lower than baseline. 
TP-1 :PRE, TP-2:5'P.V, TP-3:5'I.V,C , TP-4:5'H.A. 
TP-5 :30'Revasc. TP-6:6hrs.revasc. DAY J:Postop. 
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PROLOGUE TO DISCUSSION. 
Analysis of data is divided into three chapters. 
Firstly, because of the large amount of data, the important 
correlation between technical aspects of transplantation and 
post-operative function, as assessed biochemically, is 
dicussed in general and then secondly considering the 
individual procedures with special emphasis on the method 
that is currently regarded as the best available (U.W. 
solution)171,172 and the simple cold storage technique, 
which is novel. 
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CHAPTER 10. 
DISCUSSION: PART I 
THE EFFECT OF TECHNICAL ASPECTS 
IN LIVER TRANSPLANTATION. 





This method of donor hepatectomy allowed harvesting in 
less than 20 minutes. All dissection was done in the donor 
animal whilst the liver was normally perfused. The possible 
harmful effect of dissection on a cold, ischaemic organ was 
avoided.s This technique also allowed for exactly the same 
procedure in allo- and autografts. In cases where portal 
vein cannulation was performed, arterial perfusion of the 
liver was not interrupted until removal of the liver. The 
warm ischaemic time of the liver prior to flushing, 
utilising this method, was usually less than 30 seconds. 
Some authors pay extraordinary attention to minimising this 
period of warm ischaemia. Results obtained in this series of 
experiments questions the relevance of brief warm ischaemia 
time164, as do previous studies by Kahn et al who 
demonstrated that minimal changes occurred in liver enzymes 
after 30 minutes' total vascular occlusion under 
normothermic conditions,123 
OPERATIVE TECHNIQUE, 
All implantations were done in exactly the same manner 
and anastomotic sequence. Operative times were similar in 
all groups regardless of the procedure being allo-or 
autograft. Total intra-operative times were less than one 
and a half hours in all cases. This differed markedly from 
previously described methods and techniques. Also, heparin 
administration was much lower than used earlier in our 
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laboratory as well as described in the literature, 
especially by the earliest workers such as Cordier,1,2,4,6 
The postoperative fluid and drug management was standardised 
and kept within narrow limits. 
IMMUNOSUPPRESSION. 
No immunosuppression was given, as was standard 
procedure in our laboratory, following the observations made 
by Terblanche 2, Calne 7 and others. The 
teaching, that the allogeneic transplanted pig liver does 
not reject easily, however, has recently been questioned. 
(Sacks D,; Personal comaunication.) However, acute or 
hyper-acute rejection of the liver was not evident in this 
series of experiments. 
In more than 50% of transplanted animals in this 
series, a rise in serum A,S,T, coinciding with cholestatic 
jaundice occurred between days 4 and 6. In 50% of these 
animals this was a transient occurrence, but the rest 
succumbed to what seemed a rejection episode, after day 7. 
The use of immunosuppressive drugs, however, is not 
without side effects. Immunosuppressive drugs are 
non-specific and cause decreases in all immune responses,159 
In this study rejection did not seem to play a role early in 
the postoperative period; liver function and changes thereof 
could be assessed, without the possible harmful effects of 
immunosuppression on liver function, immediately and in the 
first week following liver transplantation. 
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Survival of 91% was obtained, in transplanted animals, 
for the duration of the study (30 out of 33). 
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CHAPTER 11, 
DISCUSSION: PART II 
THE EFFECT OF LIVER TRANSPLANTATION 











Calcium is the 5th most abundant element in the human 
body and the most common of the mineral ions comprising 
approximately 2% of body weight. The ECF concentration of 
the ion is kept within narrow limits to permit its action in 
a multitude of metabolic processes, one of the most 
important of which is coagulation of blood. It also plays an 
important role in the control of enzyme functions and as a 
messenger in the transmission of hormone actions,106 
The vital role that calcium plays in myocardial 
contraction was proved more than a 100 years ago by 
Ringer,120 The observation that calcium in plasma existed in 
more than one fraction was made in 1911, but these were only 
defined in 1934,1oa,109 Definition of the three plasma 
fractions of calcium universally accepts ionised (50%), 
complexed but diffusible or ligand bound (10%) and protein 
bound (40%) forms.110 
The complexed form of calcium in plasma is bound to 
citrate, bicarbonate and phosphate. This is the smallest 
fraction of calcium and no physiological activity or role 
has yet been ascribed to it. Determination of this fraction 
is difficult and depends 
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on factors such as pH, concentration and affinity of the 
various ligands to ionised calcium.111 
The ligand bound form of calcium might be important in 
the acute control of calcium concentration in plasma. It has 
been shown that in lactic acidosis ionised calcium levels 
will decrease by formation of calcium lactate,1 25 
Protein-bound calcium accounts for a major portion of 
calcium in plasma. Calcium binds to globulins (all four 
fractions) and albumen with the following affinity. 
Albumen>gamma->alpha 1->alpha 2->beta globulinlll 
It is thus clear that any change in the relative 
quantities of the different protein fractions will exert 
major changes on the total to ionised calcium ratio. This 
has been shown to be true in patients with liver cirrhosis, 
where measured plasma ionised calcium concentration were 
higher than calculated values, in order to maintain calcium 
homeostasis,112 
It has previously been noted in clinical liver 
transplantation that there was a marked fall in the 
concentration of total calcium postoperatively,113,168,169 
This was ascribed to the use of citrated blood during the 
procedure, where up to 30 or 40 units of blood may be used. 
These authors suggested that 2.5 mMol of calcium chloride 
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should be given for each unit of blood administered. They 
observed that most of the patients in their study had raised 
ionised serum calcium levels postoperatively (after 
receiving intravenous calcium chloride as suggested) but 
this was corrected spontaneously,113 Other authors have 
shown that even after massive transfusion, ionised calcium 
levels returned to normal as soon as citrate was metabolised 
and that empirically administered calcium might be 
deleterious,126 
The importance of maintaining normal calcium levels 
rests in its contribution to cardio-vascular function and 
stability. Some investigators have attributed the inability 
to maintain the hyperkinetic cardiac state seen in some 
liver transplant recipients to calcium deficiency,103 It has 
also been suggested that immediate correction of changes in 
ionised calcium should be made by administration of calcium 
chloride to prevent citrate toxicity,124 A second reason for 
calcium supplementation would be prevention of hypocalcaemic 
tetany,86 
The liver has the lowest intracellular concentration of 
calcium in the body at 1,6 mMol Ca++/kg wet weight (muscle 
8.9, kidney 6.4). 
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This is significant because of the action of calcium as 
a messenger in the cytosol, control of membrane permeability 
to itself as well as other ions and also because of its 
direct action upon processes such as phosphorylation and DNA 
synthesis. If a breakdown in the integrity of the ion 
channels in the cell membrane occurs, there will be a flux 
of calcium and other ions into cells, based on concentration 
only,106. It has been noted that there is an extremely steep 
gradient between intra- and extracellular ionised calcium 
levels with an important functional purpose.see Chapter 3: 
Calcium. 
During organ storage for transplantation cellular and 
membrane damage occurs,114,115 The role of calcium as 
initiator as well as mediator in cell death has been 
described87, and upon reperfusion of the organ, the action 
of oxygen free radicals would cause further cell wall 
damage,116,117 It is clear that if excess calcium is 
circulating, further damage to cells already damaged by 
hypothermic storage and reperfusion injury may be caused by 
an increase in intracellular calcium and inability of energy 
dependent mechanisms to extrude this. 
In critically ill patients calcium homeostasis is 
grossly deranged; such patients tend to have low total 
calcium levels, but it has been found that even in them 
ionised calcium remains within a narrow, albeit low 
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normal, range. Myocardial and other cellular functions are 
adapted to these lower levels of calcium.118 
The level of ionised calcium may be chronically 
low in relation to established "normal" values. In the 
patient population for liver transplantation, organ systems 
other than the liver, such as renal (hepato-renal syndrome) 
and respiratory (intra pulmonary shunting) are often 
compromised. These patients are often hypoalbuminemic and 
hypokalaemic, and might appear on laboratory data alone to 
be hypocalcaemic (total as well as ionised). Functionally, 
however, these patients are in calcium homeostasis. In the 
absence of acute symptoms, prophylactic treatment of 
presumed or projected hypocalcaemia may be deleterious eg. 
disturbances of cardiac rhythm.107 
Ionised calcium is the functionally active form of this 
essential mineral. It has been shown that ionised calcium 
concentration changes inversely to changes in pH associated 
with respiratory alkalosis or acidosis at a rate of 
0.4mMol/L per pH unit.121 It has also been established in a 
model of metabolic acidosis that a decrease in pH will raise 
ionised calcium, but that very little effect is exerted on 
total or protein bound calcium .122 
In the groups of transplanted animals in this study 
reference values of calcium correlated well with those 
reported by other investigators using pigs as 
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experimental models,122 
In both auto- and allograft graft groups there was an 
immediate decrease of total calcium upon reperfusion, There 
was no transfusion of blood or blood products, at any time, 
to account for this decrease. No drugs that could affect 
calcium values were given to any animal. 
Variables in the composition of the solution (pH, 
calcium) used for flushing of the liver may contribute to 
changes in measured values after reperfusion. It is noted 
that Eurocollins and U.W solutions do not contain calcium, 
whereas lactated Ringers solution does. However, there was 
no difference in calcium values of auto- and allograft 
groups regardless of flushing or not. 
In group 2 (lactated Ringers solution) a 0.1 mEq/L 
higher value was seen at TP 3 through to day 3. This was 
only statistically significant after reperfusion of the 
hepatic artery, Lactated Ringers solution contains 2 mMol/L 
of calcium ion. It could be argued that this would account 
for the higher values in this group of animals, but this is 
an unknown quantity as no actual measurement of the volume 
remaining in the liver was made. Some of this was flushed 
out by blood after anastomosis and restitution of flow 
through portal vein.see Chapter 5: Technique. 
The hepatic venous concentration of ionised calcium 
showed no change up to thirty minutes after full 
revascularisation, In the same period marked fluctuations 
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in total calcium values occurred. 
The pH in the Ringers flushed group rose earlier than 
in the no-flush group which might account for the slightly 
higher levels of calcium up to thirty minutes post full 
revascularisation. It does not explain the statistically 
significantly lower ionised calcium at TP 6 and days I and 2 
in group 1 animals, 
Levels of plasma bicarbonate, lactic acid and albumen 
were similar in both groups. Theoretically competitive 
binding sites for ionised calcium would have been similar 
and would thus not account for discrepancies in values 
between these two groups either. 
In Collins solution stored livers total and ionised 
calcium concentration in arterial and venous blood showed an 
almost identical picture, Ionised calcium was higher than 
reference values in the first 24 hours, but normalised at 
day 1, It is of note that Collins solution does not contain 
calcium, but does contain magnesium.Table 1. 
Changes in pH would account for changes in ionised 
calcium in group 3 (Collins), but not for that in total 
calcium.122 Plasma bicarbonate in this group remained 
statistically significantly lower than in the other 
allograft groups yet ionised calcium levels were higher at 
comparative timepoints. 
Lactic acid concentrations in the allograft groups 
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were identical and thus calcium complexing to lactic acid 
cannot account for variation in values,125 
Mechanisms for the acute control of calcium homeostasis 
have not been clarified,120,122 It seems that in the 
transplant setting changes in calcium homeostasis occur 
independent of transfusion of citrated blood, pH changes or 
protein metabolism. Variation in calcium values does not 
follow theoretical, predicted paradigms. 
In considering plasma levels of aspartate amino 
transferase as an index of hepatocyte damage, no correlation 
could be found with total or ionised calcium levels; e.g. 
plasma aspartate aminotransferase was highest in recipients 
of simple cold stored livers yet changes in total and 
ionised calcium were moderate. 
This consideration of recognised factors in calcium 
homeostasis has not revealed consistent correlations and 
thus, in this setting, changes in calcium levels seem to 
occur independantly of changes in pH, albumen or hepatocyte 
damage. There does not appear to be any consistent 
correlation between levels of plasma calcium and electrolyte 
composition of flushing solutions,Vide supra, 
It is apparent that further studies will be necessary 
to elucidate causes, but from this data it can be concluded 
that changes in plasma calcium occur as part of the liver 
transplant procedure per se. 
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MAGNESIUM. 
The importance of magnesium is recognised in a wide 
range of biological processes but homeostasis is not as well 
understood as in the case of calcium, although it is 
recognised as an essential mineral,54 
There is no reference to changes in magnesium in 
transplant literature, or the possible effect thereof upon 
metabolism in the recipient. 
Hypocalcaemia leads to increased absorption of 
magnesium in the loop of Henle which leads to mild 
hypermagnesaemia,127 As it has been shown that hypocalcaemia 
is a common finding in chronic liver disease128, there may 
also be an increase in magnesium concentration, 
Hypercalcaemia leads to hypomagnesaemia by a reversal 
of the renal mechanism alluded to above,127 The clinical 
effects of magnesium deficiency manifest as altered mental 
state as well as hyperexcitability in neural, cardiac- and 
somatic muscular tissue. Very subtle changes in plasma 
magnesium concentration may cause symptoms in neural and 
cardio-vascular systems, but tissue concentrations 
(especially muscle) will show depletion much earlier. 
Hypomagnesaemia is often seen in intravenously fed patients 
and potentiates the effects of hypokalaemia and digitalis on 
cardiac function; it is essential that magnesium should be 
added to intravenous hyperalimentation regimens,130 
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No adverse effects of hypermagnesaemia have been 
described, except that on a theoretical basis reduced 
absorption of calcium in the distal tubule might occur,129 
In the liver transplant setting the importance of 
magnesium lies in the possibility of renal mediated 
hypomagnesaemia caused by excessive administration of 
calcium, Intravenous alimentation, without additional 
magnesium, may increase this defect. 
In all transplanted animals an increase in total 
magnesium occurred during the first 24 hours. In autograft 
groups this increase was significantly less than in 
allografted animals and levels had returned to normal by 6 
hours post-reperfusion. 
The significantly higher magnesium levels in group 4 up 
to day 2 may have been due to magnesium contained in Collins 
solution.Table 1, Influx of water into liver cells drags 
potassium as well as magnesium into the cell,131 It has been 
shown that cell swelling with this type of preservation 
solution (Collins) is much more than with U.W. solution, 
which has been shown to decrease cell volume.so However, U.W 
solution also contains magnesium in the same concentration 
as Collins solution and no similar increase was seen in 
recipients in that group. Increased plasma levels of 
magnesium might be an indicator of cellular damage in the 
liver with release upon reperfusion. This is also indicated 
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by increased plasma magnesium levels in hepatic venous blood 
at TP 2, whereas at TP 3 (return of pooled blood from the 
lower limbs and kidneys} plasma levels were lower than at TP 
2 in all but group 4, Thus, it is possible that after 
reperfusion, swollen cells would lose magnesium along with 
potassium, as part of the reperfusion phenomenon. The 
magnitude of increase in magnesium concentration, in this 
series of experiments is in keeping with this postulate. The 
increase in serum magnesium should be correlated in the 
experimental and clinical situation with known parameters of 
functional assessment, 
Maintelyte~ intravenous solution contains 5 mEq of 
magnesium per litre but as it was given to all animals in 
the same quantities, the effect of administered magnesium 
should be ignored. 
As in the case of calcium, it would be difficult to 
deduce the concentration of ionised magnesium, by methods 
other than direct measurement. It is likely that calculated 
values for ionised magnesium would be inaccurate as with 
ionised calcium. It is accepted that with magnesium, as with 
calcium, the ionised fraction is the metabolically active 
form. This would explain symptoms of hypomagnesaemia in the 
presence of normal or near normal plasma magnesium. 
These results indicate that magnesium metabolism 
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after liver transplantation, should be investigated further 
as an early marker of preservation damage or return of 
function. 
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ACID BASE METABOLISM. 
pH 
As is well described in literature, pH declined upon 
reperfusion of the transplanted liver. The return of pH to 
normal did not differ between allo- and autograft groups, 
except for group 2 (lactated Ringers flush) and 5 (no 
flush), where the significantly earlier return to normal 
started immediately after portal reperfusion. Metabolism of 
residual lactate ion present in vascular spaces from 
flushing with lactated Ringers solution via the Cori cycle 
is a theoretical explanation for this phenomenon. Serum 
lactic acid in group 2 was higher than in non-flushed livers 
but not statistically significantly so, as in the case of 
pH. 
The reason for the earlier return of pH to baseline 
levels in group 5, which was statistically significant, can 
only be speculated upon. Anaerobic metabolism in the blood 
left in vascular spaces could have been the source of extra 
lactic acid compared to the other groups, but on measurement 
of plasma lactic acid there was no difference. Furthermore, 
in group 5 at TP 6 lactic acid, bicarbonate ion as well as 
pC02 were at the same levels as in groups 3 and 4, but the 
pH was 0.2 units higher. This would suggest the existence of 
another organic acidic metabolite not removed by the liver 
TP-5:30'Revasc. TP-6:6hrs.revasc. 
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in groups 3 and 4. This remains to be identified. 
Arterial pH levels from day 1 through 7 were higher 
than baseline levels. The metabolic alkalosis that is seen 
after human and canine liver transplantation, has been 
ascribed to metabolism of citrate administered with blood,83 
It is clear from the present account, where no blood or 
citrate was administered, that the cause for this phenomenon 
does not rest with citrate and the cause for this alteration 
in pH has also not been clarified yet. It is known that 
primary graft failure is associated with persistently low pH 
values. The identification of substances associated with 




Metabolic alkalosis often occurs in surgical patients 
due to loss of acid or addition of base. The causative 
process can usually be identified from the patient's 
condition or therapeutic management. In complex procedures, 
like liver transplantation, however reasons for development 
of this condition might not be clear,74 The frequent 
development of metabolic alkalosis post liver transplant has 
been noted and ascribed to the quantity of blood products 
used and metabolism of citrate contained therein,83,132 
Variables in the clinical setting that affect 
bicarbonate ion levels include various drugs eg. diuretics 
and corticosteroids, loss of acid via nasogastric drainage, 
ventilator management via pC02 and blood product infusion 
(citrate metabolism), Apart from nasogastric drainage during 
the operation only, none of these was present to influence 
bicarbonate production or loss in this series of liver 
transplants. 
In autograft groups bicarbonate did not decrease after 
reperfusion, but from 6 hours onward a metabolic alkalosis 
was evident. Bicarbonate ion concentration was not affected 
by lactic acid concentration. Also, the drop in pH did not 
affect bicarbonate concentration or vice versa. 
The significant decrease of bicarbonate upon 
reperfusion in allografted animals could only have been 
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caused by reperfusion of the stored liver (period of tissue 
hypoperfusion in both groups was similar). 
As was noted in autografted animals, lactic acid 
concentration did not have an effect on bicarbonate 
concentration. In group 5, although pH increased at least 6 
hours before that in group 4, bicarbonate levels were almost 
similar. In group 3 conversely, although pH at day 1 was 
still lower than other groups, bicarbonate concentration was 
at a comparable level. 
In all animals a metabolic alkalosis was present until 
day 7, with increased plasma bicarbonate concentrations, The 
development of a metabolic alkalosis in the first 6 hours 
post liver transplant is associated with survival of 
animals, whereas persistence of low levels of bicarbonate is 
seen as a poor prognostic sign,134 In a model of poor liver 
preservation, an irreversible metabolic acidosis with 
non-reversible low bicarbonate levels always resulted in 
demise of transplanted animals. Even administration of 
exogenous sodium bicarbonate and mechanical hyperventilation 
did not raise measured serum bicarbonate,134 In the three 
animals that died in this series, with no demonstrable 
cause, bicarbonate levels continued to decline. These 
animals were not ventilated nor given bicarbonate. 
The prognostic indicative value of post transplant 
bicarbonate levels is a novel preliminary observation 
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documented from our laboratory. The results obtained in this 
series of experiments suggest that post transplant 
bicarbonate levels should be assessed in the clinical 
situation as an indicator of function. 
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SODIUM 
Sodium changes in the entire series of experiments were 
unremarkable throughout. Although statistically significant 
changes were found, when compared to baseline values, all of 
these were well within normal range and clinically not of 
note. Even flushing the liver with lactated Ringers 
solution, with a high sodium content compared to other 
solutions, had no measurable effect on sodium metabolism. 
It seems that the suggested important role of the liver 
in volume regulation82, as a function of sodium 
concentration, does not come into effect in liver 
transplantation. The total denervation of the liver is 
presumed to be the cause for this phenomenon in the 
transplanted liver. Hormonal effects mediated via the 
adrenal gland is not thought to exert influence in the 




An immediate increase in serum potassium levels was 
seen in all groups upon reperfusion. Since no exogenous 
potassium was given in group 1, the source in all groups was 
most probably due to the reperfused liver, The only sources 
for this which could be identified would be haemolysis of 
red blood cells upon reperfusion or release from 
hepatocytes, 
Both Collins and U.W. solutions contain intracellular 
concentrations of potassium, yet the increase in potassium 
concentration was not different from that seen in the 
non-flushed groups. This would confirm that the increases in 
potassium were due to release from reperfused hepatocytes. 
Accepted transplant dogma requires livers to be flushed with 
large volumes of low potassium solutions prior to 
reperfusion, Although all livers in these experiments were 
flushed with autologous blood this did not change the 
transient hyperkalaemia. The observation of hyperkalaemia, 
after reperfusion, even in non-flushed livers questions the 
advisability or need to flush livers prior to reperfusion 
with large volumes of lactated Ringers solution,135 
Similar conclusions explaining the increase in 
potassium level during liver transplantation have been drawn 
by other authors,83,86 
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A significantly lower potassium was seen in group 4 at 
TP 5. This phenomenon was also seen in canine liver 
transplants and was ascribed to uptake of potassium by 
functioning hepatocytes.45,46,78 This was corrected 
spontaneously by TP 6. 
Reperfusion of the distal systemic circulation (release 
of infrahepatic inferior vena clamp) did not appear to cause 
any rise in potassium concentration in any group. 
Potassium homeostasis in all groups was normal at 6 
hours postransplant. 
No animal showed severe cardiac reactions relating to 
higher levels of potassium circulating at time of declamping 
of the suprahepatic vena cava, although ECG tracings were 
not taken. 
TP-1 :PRE. TP-2:5 ' P.V. TP-3:5 '1.V.C. TP-4 :5'H.A, 




Concentrations of K+ at all timepoints were almost 
identical in all groups except 5. The significant difference 
of 3.5mEq/L between arterial and venous samples, at TP 2 
only, with virtually no difference in other groups cannot be 
explained. The lung, as far as could be ascertained, has 
never been described as a potassium trap. At TP 3 potassium 
levels were comparable to those in other groups as well as 
to those in arterial blood. 
The importance of this discrepancy lies in the fact 
that potassium rich venous blood enters the cardiac 
circulation first and might cause serious rhythm 
abnormalities. In these experimental animals no untoward 
reactions were seen despite high serum potassium 
concentrations. 
The clinical implication of this would be to sample 
central venous blood for potassium determination, especially 
on portal venous reperfusion, as arterial blood might not 
reflect true potassium concentration fluctuation. 
TP- 1: PRE . TP-2 :5' P. V. TP-3:5 'I .V.C. TP-4 :5'H.A. 
TP-5:30' Revasc. TP-6 :6hrs .revasc. 
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LIVER FUNCTIONS. 
ASPARTATE AMINOTRANSFERASE (A.S.T) 
Levels of this enzyme are often used to indicate damage 
during storage in vitro in storage medium.so The serum level 
post transplantation is used as a parameter for return of 
function as well as repair of storage induced injury to 
hepatocytes,45,46,47 Isoenzymes are present and forms 
originating from the liver can readily be identified. The 
important other sources of this enzyme are cardiac muscle 
and red blood cells,59 In these experiments with healthy 
young pigs, cardiac muscle was unlikely to be abnormal and 
thus the possible cardiac origin of the enzyme was excluded. 
In autograft groups virtually no increase of A,S,T was 
seen during reperfusion. The increase in both groups up to 
day 1 indicated ongoing cellular disruption and 
mitochondrial breakdown. Because liver grafts were returned 
to the same animals . there was no possibility of immune 
mediated cytotoxic reaction in these groups. A likely cause 
was oxygen free radical damage, which occurs upon 
reperfusion,136 The reason for lower levels, although not 
statistically significant, in lactated Ringers flushed 
autografts is not clear. This is not an intracellular 
solution, but contains an extra cellular like concentration 
of sodium and is slightly hypo-osmolar. This solution causes 
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marked hepatocyte swelling in perfused livers,78 Also, if 
A.S.T was from red blood cells left behind in the 
non-flushed groups the rise in plasma concentration would 
have been expected earlier. 
In allografted groups the haemolytic theory would 
explain early high values in group 5, From groups 3 and 4 it 
appears that an ongoing process is causing a continuous rise 
in A.S.T levels. 
University of Wisconsin solution has been reported to 
give superior results in clinical, rat and canine liver 
preservation studies when compared to Euro Collins solution; 
one of the main parameters of preservation quality in these 
studies is postoperative serum levels of A.S.T and the rate 
of return to normal levels in the postoperative 
period,45,46,47,78 The reason for peak levels of A.S.T in 
U.W solution preserved livers, twenty four hours later, and 
higher serum levels for two days longer than in other 
groups, is obscure. The inability to preserve viability in 
porcine livers for extended periods, up to 24 hours, might 
be linked to this observation,134, Sheil R,;personal 
coamunication, 
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ALANINE AMINOTRANSFERASE (A,L,T) 
Alanine aminotransferase is used in conjunction with 
aspartate aminotransferase to assess preservation 
damage,45,46,47 It as also used in conjunction with A,S,T to 
indicate rejection episodes,137, Belzer F. :Personal 
communication, 
Although values in some instances doubled at day 1, 
there were no obvious differences between groups. In some 
pigs fulminant rejection, shortly after day 7, could not be 
predicted from serum value changes in this enzyme, 
Biochemical changes which were compatible with transient 
rejection episodes likewise were not associated with any 
rises in serum concentration of this enzyme, 
Neither A,S,T nor A,L,T or ratios of the two enzymes 
could be used to indicate the damage caused by different 
length of storage in these experiments. Serious doubts must 
exist about the use of these enzymes as an indicator of 
cellular damage in the transplant situation. 
The use of glutathione S-transferase assays might be a 
more sensitive assessment of preservation and reperfusion 
damage and should possibly be investigated in the transplant 
setting, 
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ALKALINE PHOSPHATASE (A.P) 
In autograft groups slightly increased values were seen 
which peaked at day 1, In the absence of rejection phenomena 
this would indicate some degree of biliary canalicular 
obstruction, resulting from cell swelling. As would be 
expected bilirubin levels were normal in these animals. 63 
The increase in plasma alkaline phosphatase in group 3 
(Collins solution) may also be explained by cellular 
swelling. It was shown that Collins solution caused markedly 
more swelling of cells during hypothermic storage than U.W 
solution,114 As with autografted animals bilirubin levels 
were within baseline ranges in all allografted groups. 
Levels of alkaline phosphatase in these animals at day 7 
were still within the baseline range, despite increases in 
aspartate aminotransferases and a clinical picture of graft 
rejection. 
The specificity, as well as sensitivity, of plasma 
alkaline phosphatase levels as a marker of pathology in the 
post liver transplant setting seems to be less than that of 
other, already questionable, measurements. 
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TOTAL PROTEIN 
Baseline values of total protein varied widely and the 
same wide variation existed in the postoperative period in 
all groups. Actual intravascular fluid volume is important 
in protein concentration determination,140 The gradual 
decline seen in autograft groups up to day 2 postoperatively 
could be explained by the dilutional effect of intravenous 
fluid therapy, since concentration increased from day 3, 
when intravenous infusion was stopped. 
In allograft groups the significantly higher total 
protein in group 4 (U.W. solution) up to 6 hours 
postoperatively might also have been due to fluid shifts. It 
has been shown that U.W. solution actually reduces 
hepatocyte volume and total tissue water.so Movement of 
intravascular water into the transplanted liver during the 
first 6 hours could have resulted in a relative higher 
intravascular total protein level. 
When the values for packed cell volume are assessed in 
conjunction with total protein values it appears that 
changes are not interrelated. The marked reduction in total 
protein in Collins and no-flush autografts has no effect on 
packed cell volume or vice versa. In the U.W group both 
packed cell volume and total protein remained very close to 
baseline reference values. 
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ALBUMEN 
Contrary to reported literature albumen levels in all 
groups remained within reference values for the first week. 
The only decrease was seen in the immediate post-reperfusion 
period and that was transient and insignificant. 
There is no readily available explanation for the 
discrepancy in albumen:total protein ratio observed in group 
4 (U.W. solution), In this group albumen was lower relative 
to total protein, On speculative basis, fluid drag of 
albumen into hepatocytes might be implicated in causing 
relative loss of intravascular albumen, into other fluid 
compartments. In order to prove this hypothesis the actual 
size of relevant compartments could be established by 
I125-labelled tracer albumen. This discrepancy was rectified 
spontaneously and did not prove to be significant in the 
postoperative course, 
It was shown that, although protein synthesis and 
breakdown increase up to 50% in the perioperative period142, 
the most likely cause for acute changes in albumen 
concentration during this time is alteration in fluid 
composition, These authors furthermore suggested that 
albumen concentration per se was not an indication of rate 
of synthesis or catabolism unless volume of albumen 
containing pools was taken into consideration. 
The rate and magnitude of changes in albumen 
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concentration were similar in all groups regardless of 
storage or perfusion solution variation. Synthetic function 
of the liver does not appear to have been compromised in 
this series of experiments. This was contrary to the 
observation made in ultra long term liver preservation in 
dogs where albumen levels at 6 hours after grafting were 
very low and never returned to normal.46 
These authors suggested that the albumen synthetic 
facilities in the liver were irreversibly damaged by long 
term preservation damage. 
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GLUCOSE 
Glucose levels in all pigs during the dissection phase 
were higher than post-absorptive normal levels (50-70 
mg/dL). Elevated levels were most probably due to infusion 
of 10% MaintelyteR initiated ±15 minutes prior to sampling. 
No sampling was done during the anhepatic phase which 
was shorter than 20 minutes in all cases. Anhepatic time was 
recorded from disconnection of the liver till restoration of 
portal flow. 
The increase in glucose levels on reperfusion was in 
keeping with experimental and clinical reports.85,144,146 
Experimental work done on dogs showed a similar increase in 
Phase I (pre-anhepatic) to what was seen in all pigs, except 
that no dextrose was administered during the entire 
procedure in dogs.144 Also, in clinical transplants, it was 
shown by Atchison that the amount of dextrose administered 
in blood products, did not bear relation to the rise in 
glucose on reperfusion of the donor liver.71 In groups 3 
(Collins) and 4 (U.W.) extra glucose was present in the 
storage fluid, However, blood glucose levels on reperfusion 
showed a similar increase in all animals. 
The overall lower glucose levels in group 4 (U.W,) 
immediately after reperfusion, although not statistically 
significant, indicated either less leakage or earlier uptake 
of glucose. It is more likely that leakage of glucose out of 
cells was responsible for high blood levels.146 
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The statistically significantly lower level at thirty 
minutes after reperfusion indicates that livers were 
actively metabolising glucose, Also, it is noted that in 
group 3 there was a downward trend in glucose levels at 
thirty minutes postreperfusion. These two groups had 
additional glucose (added to the preservation solution) 
compared to the others. It could be suggested that less 
glycogenolysis and glucose loss from hepatocytes due to 
glucose loading, would result in earlier availability of 
hepatic substrate and thus earlier return of energy 
production by the liver, 
In three non-surviving pigs (data not shown) blood 
glucose levels at 6 hours postreperfusion were above 400 
mg/dL. This concurred with the view that persistent 
hyperglycemia in the postoperative period is a poor 
prognostic indicator,143 As shown by Hickman, hepatectomised 
pigs with persistent hyperglycaemia have an extremely short 
survival period compared to those where the blood glucose is 
kept at normal levels,160 
Khoury and his group theorised that the decrease of 
glucose on reperfusion, was due to decrease in the glucose 
load administered in blood, because transfusion requirements 
diminished during the same period,145 These results show 
that the theory is unfounded; in all animals in this series, 
despite the continuous infusion of a 10% dextrose solution, 
glucose levels were maintained comparable to what would be 
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expected in the absorptive (postprandial) state 
(90-lOOmg/dL). Thus, glucose levels in the postreperfusion 
period, decrease due to active metabolism by hepatocytes. On 
discontinuation of dextrose infusion, early morning blood 
glucose levels were similar to those seen in the 
pre-prandial state (50-70 mg/dL). 
121 
LACTIC ACID 
Lactic acid levels in all groups were compatible with 
normal levels reported in the literature and accepted in 
J.S. Marais laboratory.BO 
Increase in lactic acid levels upon reperfusion was 
expected for theoretical reasons. The seemingly higher 
values in group 2 (lactated Ringers) was not of statistical 
significance and percentage increases were exactly similar 
to those seen in other groups. This indicates that an 
insignificant volume of remaining lactated Ringers solution 
was put into circulation on reperfusion. 
Opening of the inferior vena cava, in both groups, 
resulted in an increase in lactic acid levels. This 
indicates introduction of lactic acid from the temporarily 
occluded distal systemic circulation. The magnitude of this 
increase was statistically, and in real terms, 
insignificant. In autograft groups the isometric maintenance 
of this level could indicate earlier return of hepatocyte 
function, because the influx of lactic acid from distal 
systemic circulation in both groups must have been 
equipollent. 
The increase in plasma levels of lactic acid on 
reperfusion did not differ between the prolonged storage and 
autograft groups, and was unexpected. A possible explanation 
for this might be a rate limiting effect of anaerobic 
metabolism by decreasing pH intracellularly.136 
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The significantly lower levels at thirty minutes 
postreperfusion, in the autograft groups, indicate earlier 
return of metabolic capacity. It remains a question whether 
the reason for this is qualitative at a cellular level or a 
function of hepatic volume as a quantitative factor. It 
seems logical to accept that quality of function is more 
likely, 
When this part of carbohydrate metabolism (lactic acid) 
is compared to that of glucose it is noted that in the first 
thirty minutes after complete revascularisation, in 
autograft groups, lactic acid concentration was lowered 
before that of glucose. This is in keeping with the concept 
of no nett gain in glucose by aerobic conversion of lactic 
acid to glucose. Conversely, in group 4 (U.W. solution) 
glucose levels declined whilst lactic acid concentration 
remained stable. There is no readily available explanation 
for this phenomenon. 
The alkalosis that developed in all animals from 6 
hours and remained till day 7 happened despite normal lactic 
acid levels. This finding indicates that metabolism of 
excess circulating lactate cannot be the cause of ongoing 
metabolic alkalosis seen after liver transplantation as 
suggested,145 
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In three pigs that did not survive, lactic acid 
concentration was increased at 6 hours postoperatively. This 
phenomenon was also seen in pigs transplanted with extended 
preservation time (24 hours) livers,Unpublished data and all 
of these animals died in metabolic acidosis. 
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BILIRUBIN 
Bilirubin changes, as mentioned, were not indicative of 
storage related functional abnormalities. The changes seen 
in 50% of the animals were indicators of rejection and had 
no relation to the storage time or perfusion fluid. 
The fact that no choledochal strictures were seen at 7 
days could be artefactual due to the short time span. 
However, this type of anastomosis is used clinically and 
experimentally with success,46,47,48 Furthermore, the pig is 
not susceptible to biliary complications after liver 
transplant, probably due the excellent blood supply to the 
common hepatic duct as shown by Northover.43 
It seems that bilirubin levels are not an indicator of 




DISCUSSION: PART III 
THE EFFECT OF LIVER TRANSPLANTATION 
ON COAGULATION. 
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COAGULATION CHANGES IN LIVER TRANSPLANTATION, 
Coagulation profiles in the clinical and laboratory 
settings of liver transplantation vary. 
Clinically, the indication for transplantation often is 
extensive liver pathology and this is frequently the direct 
cause of pre-and intraoperative haemostatic 
abnormalities,147,148 
In the spectrum of liver disease there is a qualitative 
as well as quantitative difference, in clotting 
abnormalities presenting, directly relating to underlying 
pathology,149 
The basic pathology may vary from a defect in the 
manufacture of essential clotting components such as factors 
V, VII, VII and others to plasminogen activators,149 The 
existence of a plasminogen activator in bile has been known 
since 1983, although the role of this substance in liver 
transplantation has not been investigated,150 Tissue 
plasminogen activation as well as other coagulation 
parameters are extensively investigated in liver 
transplantation with a view to identifying prognostic 
indications, as well as the origin of coagulation defects. 98 
Clinical liver transplantation is the surgical 
procedure associated with the use of highest volume 
transfusion of blood and or blood products and all possible 
should be done to decrease requirements,151 
127 
The situation in experimental transplantation is quite 
different from the clinical as far as haemostasis is 
concerned. Normal haemostatic mechanisms should be expected 
in donor as well as recipient. Any changes in haemostatic 
parameters will be affected by the procedure or preservation 
flushing solutions and iatrogenically administered drugs 
such as heparin, 
In experimental transplantation defects in haemostasis 
have been shown to cause mortality,152 In early experiments 
high doses of heparin were used both in donors and 
recipients. The role of ''heparin-like" or endogenous heparin 
has not been clarified. It is possible that administered 
heparin might bind to endothelial surfaces and be released 
on reperfusion of the grafted organ to cause clotting 
defects,153 
In experiments under discussion the only significant 
differences in clotting parameters used, were prolongation 
of activated clotting time (A.C.T), which is specifically 
designed to detect heparin action. Although the autograft 
groups only received a total of 500 Units of heparin, less 
than the 1500 Units in the donor and recipient together in 
the allograft groups, there was no difference between these 
two groups, except in livers preserved in Collins solution. 
In all animals A.C.T levels were back to normal by 6 hours 
postoperatively, Judging from this data it seems that the 
heparin given to the donor did not cause prolongation of 
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A,C,T. in transplanted animals except in the livers 
preserved with Collins solution, where it was transient. 
The ''haemorrhagic diathesis" reported in the literature 
by Perkins, as well as Plevak and Porte, occurred in livers 
preserved with crystalloid solutions such as Collins or 
lactated Ringers,152,154,155 This grave complication did not 
play any role upon reperfusion of the donor liver in any of 
the experiments reported in this study. 
Similarly, a decrease in fibrinogen concentration is a 
common finding after major surgery or resection,lSS The 
insignificant differences of values between autograft and 
allograft groups indicates that the decrease in fibrinogen 
was related to the magnitude of the surgery, and had nothing 
to do with storage or dilutional effects of preservation 
solutions. 
Platelet counts, although differing widely, did not 
change significantly in any of the groups. The decline seen 
after 6 hours in all groups and the return to normal levels, 
is in keeping with the trend reported by other 
investigators,155 
Decreases in platelet counts associated with liver 
transplantation have been ascribed to sequestration in the 
donor liver spaces of Disse,156 It was suggested that 
platelets aggregated as a faculty of reticule-endothelial 
stimulation, with a resultant decrease in absolute 
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numbers, and were then released as non-functioning units 
with a low normal absolute platelet count as result, but 
functionally deficient. It was also thought that platelets 
were actively ingested by the donor liver Kupffer cells. 157 
In patients with liver disease, necessitating hepatic 
transplantation, thrombocytopenia as well as abnormal 
platelet function is known to co-exist. Platelet transfusion 
is an essential element of haemostatic management intra- and 
postoperatively,149 
In these experiments platelet counts showed some 
decrease in absolute numbers. In no case did an absolute 
thrombocytopenia or haemostatic defect attributable to 
platelet dysfunction develop. The lower values in allograft 
groups could have been due to platelet aggregation on 
damaged endothelial surface due to storage or as part of a 
immune response by the reticule-endothelial system. These 
experiments indicate that the decrease in platelet numbers 
does not cause a bleeding diathesis and also that the donor 
liver is not a cause for qualitative or quantitative host 
platelet defects. 
Packed cell volume is an indicator of blood composition 
and as such specifically of the red cell mass. The massive 
transfusion requirement of liver transplantation is well 
known,158 Notwithstanding total absence of blood 
transfusion, packed cell volume decreased to clinically 
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acceptable levels in this series and remained at that level. 
It seems that neither transplanted liver nor host immune 
system played a major role in the lowered packed cell 
volume. 
Data collected in this series of experiments indicate 
that the transplanted liver per se, does not have any effect 
on packed cell volume. Changes which do occur are due to 







In formulating conclusions from the vast amount of data 
collected in this series of experiments, it is important to 
briefly paraphrase the hypothesis or questions asked in this 
study, namely if the handling and storing moiety of the 
liver transplant procedure plays any role in changes in 
standard parameters seen after transplantation. It should 
also be kept in mind that this study was not used to compare 
different methods of storage, but that variations seen were 
used in an attempt to elucidate the mechanism responsible 
for the observed changes. 
The comprehensive conclusion regarding the five groups 
of transplanted animals definitively affirms that the 
process of transplantation of the liver, per se, does cause 
major changes in biochemical parameters of liver function. 
Contrary to earlier beliefs, transplantation had minimal 
effect upon coagulation, and it is clear that changes in 
coagulation parameters reported by earlier studies, were due 
either to iatrogenic pharmacological manipulation by heparin 
administration or preservation damage. It can be postulated 
that the effect of the donor state and/or preservation 
damage will cause exponential decline of function, which 
will be cumulative to those changes elicited by the 
transplant process. The excellent function of non-flushed 
livers challenges current preservation dogma that flushing 
of livers is essential. 
The decrease in total, as well as ionised calcium, 
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that occurred seems to be an integral part of complex 
biochemical changes that occur in the transplanted liver. 
Changes in calcium levels occurred independently of 
recognised intrinsic influencing factors such as pH, albumen 
and hepatocyte damage or the extrinsic effect of blood 
transfusion. It was also shown that the only correct 
quantification of ionised calcium is by direct measurement. 
The significance and mechanism of changes in magnesium 
levels, that mirrored those of ionised calcium, could not be 
explained. Further studies are essential to elucidate the 
causes of plasma level changes, in these two minerals, in 
association with liver transplantation. 
Liver transplantation profoundly affected acid-base 
metabolism. Metabolic alkalosis occurring after liver 
transplantation is not due to the metabolism of citrate or 
lactic acid, but does indicate functional hepatocytes with 
good prognosis for survival, This phenomenon should be 
investigated at cellular level. 
Measurement of "liver enzymes'' as an indicator of 
storage damage or return of function is of low specificity 
and sensitivity. Changes in these values do not correlate 
with those in other parameters. 
Normal glucose homeostasis and metabolism of lactic 
acid in the early post-transplant period is an important 
indicator of hepato-cellular function and prognosis. 
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Coagulation in porcine liver transplant recipients is 
not affected by the process of successful storage and 
transplantation. It is suggested that derangements in 
coagulation, seen clinically, 1s a complex of donor liver 
quality and/or pre-existing disease in the recipient . 
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EPILOGUE. 
The question posed has been answered affirmatively. To 
the complex interplay of factors determining successful 
post-transplant liver graft function is evidently added the 
procedure itself. A reference database for those changes due 
to transplantation of the liver, in the pig, has been set 
and several novel observations, which may have clinical 
relevance, have been made It is my hope that this study 
will be a stone, albeit small, in the foundation of a better 
understanding of liver transplantation. 
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